Disease of genetic or genomic mechanism
MONDO:7770009A grouping class for human diseases caused by genetic or genomic alterations, including chromosomal abnormalities and heritable mutations.
15804 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 2013 trials in this tab.
-
Experimental drug aims to reverse liver damage in rare triple condition
Disease control Not yet recruitingThis study tests a drug called foscenvivint in people with liver cirrhosis caused by HIV and hepatitis C co-infection who also have hemophilia. Participants receive the drug once a week for 24 weeks. Researchers will check if the drug improves liver function and is safe to use.
Phase: PHASE2 • Sponsor: Kiminori Kimura, MD • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill aims to ease Parkinson's motor symptoms when added to standard therapy
Disease control Not yet recruitingThis phase 2 trial tests whether ENERGI-F705 tablets, taken twice daily alongside standard Parkinson's medications, can improve motor function and safety in people aged 40–75 with idiopathic Parkinson's disease. Participants are randomly assigned to receive a high dose, low dose,…
Phase: PHASE2 • Sponsor: Energenesis Biomedical Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Radioactive drug targets Hard-to-Treat thyroid cancer
Disease control Not yet recruitingThis study tests a radioactive drug called 177Lu-DOTA-EB-TATE in 18 adults with a rare thyroid cancer (Hurthle cell) that has spread and not responded to standard radioactive iodine treatment. The drug is designed to seek out and attach to cancer cells. Participants will receive …
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Eye injection shows promise in preventing repeat retinal detachment
Disease control Not yet recruitingThis early-stage study tests whether an injection of the drug topotecan into the eye can safely prevent retinal detachment from coming back in people with a condition called proliferative vitreoretinopathy (PVR). About 50 adults having retinal detachment surgery will either recei…
Phase: PHASE1 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Gene therapy aims to free Beta-Thalassemia patients from lifelong transfusions
Disease control Not yet recruitingThis study tests a single-dose gene therapy for people with transfusion-dependent beta-thalassemia, a blood disorder that requires regular red blood cell transfusions. The therapy uses a patient's own stem cells, modified with a virus to produce healthy hemoglobin, and then infus…
Phase: PHASE2 • Sponsor: Fondazione Telethon • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for rare immune disorders: upadacitinib trial launches
Disease control Not yet recruitingThis study tests the drug upadacitinib (Rinvoq) in 30 people with rare genetic disorders that overactivate the JAK-STAT immune pathway. The trial has four phases over 12 months, including an open-label phase to find the best dose and a randomized withdrawal phase to compare the d…
Phase: PHASE1, PHASE2 • Sponsor: Lisa Satter • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for young adults with CML: asciminib under Real-World scrutiny
Disease control Not yet recruitingThis study looks at how well the drug asciminib works and how safe it is for young adults with chronic myeloid leukemia (CML) in the Gulf region. Researchers will collect information from medical records of about 80 people aged 18 and older who have taken asciminib. The main goal…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental drug aims to halt rare neurological decline
Disease control Not yet recruitingThis Phase 3 trial tests whether vatiquinone can slow the progression of Friedreich's ataxia, a rare genetic disorder that damages the nervous system and impairs movement. About 120 adults with moderate symptoms will take the drug for 24 months. Researchers will measure changes i…
Phase: PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill targets rosacea inflammation at its source
Disease control Not yet recruitingThis study tests an oral medication called remibrutinib for adults with moderate-to-severe papulopustular rosacea, a skin condition causing red bumps and pustules on the face. The drug works by blocking a protein involved in inflammation. Researchers will measure whether it reduc…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drugs aim to slow muscle decline in duchenne muscular dystrophy
Disease control Not yet recruitingThis study tests two experimental drugs, ENTR-601-44 and ENTR-601-45, in people with Duchenne muscular dystrophy (DMD) who have already taken part in earlier studies. The goal is to see if long-term use is safe and tolerable, and whether it can help maintain muscle function. Part…
Phase: PHASE2 • Sponsor: Entrada Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New daily pill aims to tame stubborn seizures in tuberous sclerosis
Disease control Not yet recruitingThis study tests an oral drug, AV078, in people aged 12 and older with tuberous sclerosis complex (TSC) whose seizures are not controlled by standard medications. Participants are randomly assigned to receive AV078 or a placebo for 12 weeks. The goal is to see if AV078 safely red…
Phase: PHASE2 • Sponsor: Aeovian Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
One-Time gene injection aims to rescue sight in rare childhood blindness
Disease control Not yet recruitingThis study tests a gene therapy called OPGx-RDH12 for people with Leber Congenital Amaurosis (LCA) caused by mutations in the RDH12 gene, a rare condition that leads to severe vision loss from a young age. The treatment is given as a single injection under the retina in the worse…
Phase: PHASE1, PHASE2 • Sponsor: Opus Genetics, Inc • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Gene therapy could free Wilson's patients from daily pills
Disease control Not yet recruitingThis early-stage trial tests a single-dose gene therapy called LY-M003 in 18 adults with Wilson's disease, a genetic condition that causes copper buildup. The goal is to see if it's safe and can reduce or eliminate the need for standard daily medications. Participants receive one…
Phase: PHASE1, PHASE2 • Sponsor: Lingyi Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New study tracks Real-World safety of odevixibat in rare liver disease
Disease control Not yet recruitingThis study will follow 30 people with Alagille syndrome who are taking odevixibat in their daily lives. The goal is to see how safe the drug is over the long term by tracking any side effects. It is not testing if the drug works, but rather monitoring its real-world safety.
Sponsor: Ipsen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New registry tracks Dupilumab's Real-World impact on COPD
Disease control Not yet recruitingThis registry will follow 350 COPD patients starting dupilumab (Dupixent) to see how well it works and how safe it is in real life. Researchers will track flare-ups, lung function, and quality of life over 24 months, comparing them to similar patients not on the drug. The goal is…
Sponsor: Sanofi • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pill hopes to calm Crohn's Flare-Ups
Disease control Not yet recruitingThis early-stage study tests a new drug called zasocitinib (TAK-279) in 20 adults with active Crohn's disease who have not responded to other treatments. The main goal is to see if the drug is safe and how it affects inflammation in the gut. Participants will take the drug for 12…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Smart breathing machines at home could cut hospital visits for COPD patients
Disease control Not yet recruitingThis study looks at whether adding a home telemonitoring system to standard nighttime breathing support (non-invasive ventilation) can help people with severe COPD and high carbon dioxide levels. About 92 participants will be split into two groups: one using standard home ventila…
Sponsor: Air Liquide Healthcare Spain • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
One pill may tame both itchy skin and stubborn liver disease
Disease control Not yet recruitingThis study tests whether upadacitinib, a drug already approved for eczema, can help people who have both atopic dermatitis (a type of eczema) with moderate to severe itching and a hard-to-treat autoimmune liver disease called cholangitis. The drug works by blocking a pathway invo…
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple-Drug cocktail targets Hard-to-Treat blood cancers
Disease control Not yet recruitingThis phase I trial is testing whether combining three drugs—pacritinib, venetoclax, and azacitidine—is safe and tolerable for people with accelerated or blast phase myeloproliferative neoplasms, aggressive blood cancers. The study enrolls about 20 adults whose disease has progres…
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a cream make laser treatment for birthmarks more effective?
Disease control Not yet recruitingThis study tests whether a rapamycin cream, applied after laser treatment, can improve the appearance of port wine stain birthmarks in children aged 10 and under. Thirty participants will receive laser therapy plus either a low or high dose of the cream or a placebo cream for 12 …
Phase: PHASE2 • Sponsor: AFT Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to slow kidney damage in rare alport syndrome
Disease control Not yet recruitingThis study tests a drug called exaluren in 24 people aged 12 and older with Alport syndrome caused by specific genetic errors. The drug is given as a daily shot for 32 weeks. Half the group starts exaluren right away, while the other half gets a placebo first and then switches to…
Phase: PHASE2 • Sponsor: Eloxx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
One pill to tackle three heart risks: could a polypill cut cardiovascular disease?
Disease control Not yet recruitingThis trial tests whether a single daily pill that combines treatments for high blood pressure, high cholesterol, and type 2 diabetes can lower the risk of heart disease and dementia. The study involves over 8,000 adults aged 50 to 75 in China who have all three conditions. Partic…
Phase: NA • Sponsor: China Medical University, China • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to preserve sight in rare genetic blindness
Disease control Not yet recruitingThis phase 3 trial tests whether NPI-001, taken twice daily for 24 months, can slow the loss of light-sensing cells in the eyes of adults with Usher syndrome, a genetic condition that causes both hearing and vision loss. About 80 participants will receive either the drug or a pla…
Phase: PHASE3 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Oxygen therapy may boost hip procedure for bone death
Disease control Not yet recruitingThis study tests whether adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to a standard hip procedure (core decompression with bone marrow cells) can reduce pain in people with early-stage avascular necrosis of the hip. The trial will enroll 400 p…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New oral pill H021 aims to tame Crohn's Flare-Ups
Disease control Not yet recruitingThis phase 2 trial tests whether an experimental oral tablet called H021 can help people with moderate to severe Crohn's disease. Participants receive either a low or high dose of H021 or a placebo for 12 weeks, with an option to continue treatment. The study measures symptom imp…
Phase: PHASE2 • Sponsor: Jiangsu Carephar Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
A reversible gut sleeve could offer a new way to treat obesity
Disease control Not yet recruitingThis pilot study tests a temporary, flexible tube called a duodenal-jejunal bypass sleeve. It is placed in the upper intestine using an endoscope and left for 3 months to help with weight loss and improve metabolic syndrome. The study involves 20 adults with obesity or excess wei…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered immune cells take aim at autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new treatment called C-CAR168 for people with autoimmune diseases like multiple sclerosis, lupus, and myasthenia gravis that have not improved with standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab…
Phase: PHASE1 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for kids: drug may prevent transplant complications
Disease control Not yet recruitingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children and young adults (ages 1-26) with non-cancerous blood disorders who are getting a bone marrow transplant. GVHD is a serious complication where donor cells…
Phase: PHASE2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Nasal spray ingredient may offer safer dental pulp treatment for kids
Disease control Not yet recruitingThis study tests whether oxymetazoline, a common nasal decongestant, can replace sodium hypochlorite as a bleeding control agent during pulp treatment in children's baby teeth. About 50 Egyptian children aged 4-8 with decayed molars will receive either treatment. The goal is to s…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Simple exercises may boost nerve repair in diabetic neuropathy
Disease control Not yet recruitingThis study compares two exercise programs—combined aerobic and resistance training versus seated soleus push-ups—against standard care in people with type 2 diabetes and diabetic peripheral neuropathy. Researchers will measure blood markers of nerve repair (BDNF, NGF, S100B) and …
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Dual-Pronged CAR T-Cell therapy takes aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis phase 1 trial tests a new cell therapy called KITE-753 for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to standard treatments. KITE-753 is made from a patient's own immune cells, which are modified to recognize and attack leuke…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered immune cells take aim at childhood autoimmune diseases
Disease control Not yet recruitingThis early-phase trial tests a single infusion of universal CAR-T cells (RD06-05) in 30 children and adolescents with severe autoimmune diseases, including lupus, scleroderma, and kidney inflammation. The cells are designed to target and calm overactive immune cells. The main goa…
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Old drugs, new hope: could a thalidomide combo free thalassemia patients from transfusions?
Disease control Not yet recruitingThis study tests whether a combination of two drugs, thalidomide and hydroxyurea, can safely boost fetal hemoglobin levels in people with beta thalassemia major. The goal is to improve overall hemoglobin levels and reduce the need for regular blood transfusions. The trial include…
Phase: NA • Sponsor: Riphah International University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could looser jaundice rules spare preterm babies unnecessary treatment?
Disease control Not yet recruitingThis trial tests whether using higher (less strict) bilirubin thresholds for starting light therapy in very preterm infants (born before 30 weeks) is as safe as the current Dutch guidelines. About 680 babies across Dutch NICUs will be randomly assigned to one of two threshold str…
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Sugar supplement may calm seizures and stomach troubles in rare genetic disease
Disease control Not yet recruitingThis study tests whether a sugar called D-galactose (AVTX-801) can help people with SLC35A2-CDG, a rare inherited disorder that disrupts how the body adds sugar to proteins. The trial enrolls about 10 people of any age who have seizures or chronic digestive issues. Participants r…
Phase: PHASE2 • Sponsor: Eva Morava-Kozicz • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
One-Time gene fix could free kids from lifelong diet and meds
Disease control Not yet recruitingThis early-phase trial tests a single intravenous dose of a gene editing therapy called LNP.UCD.ABE in 7 children with severe urea cycle disorders. The therapy aims to correct the genetic defect using a lipid nanoparticle to deliver a base editor. The main goal is to check safety…
Phase: PHASE1, PHASE2 • Sponsor: Rebecca Ahrens-Nicklas • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a drug tame excess cortisol in a common hormone disorder?
Disease control Not yet recruitingThis study tests whether the drug metyrapone can safely lower cortisol levels in people with mild autonomous cortisol secretion (MACS), a condition where the adrenal glands produce too much cortisol. Participants will receive either metyrapone or a placebo for a short period, and…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New surgery aims to cut pancreatic leak and diabetes risk
Disease control Not yet recruitingThis study tests a surgery called total pancreatectomy with islet autotransplantation (TPIAT) in 30 adults with certain pancreatic tumors who are at high risk for a dangerous leak after standard surgery. The procedure removes the entire pancreas and transplants the insulin-making…
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Head-to-Head: which acne cream works better for clear skin?
Disease control Not yet recruitingThis study compares two topical medications—clascoterone cream and adapalene gel—for treating mild acne vulgaris. Researchers will enroll 60 people aged 12 to 35 with mild acne and randomly assign them to use one of the treatments for 12 weeks. The goal is to see which treatment …
Phase: EARLY_PHASE1 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Tiny tablets could make PKU management easier for patients
Disease control Not yet recruitingThis study tests a new microtablet protein substitute for people with phenylketonuria (PKU), a condition requiring a strict low-protein diet. The microtablets combine protein with vitamins and minerals, aiming to be easier to take than current liquid or powder options. About 20 a…
Phase: NA • Sponsor: Nutricia UK Ltd • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can a Low-Carb diet calm kidney disease inflammation?
Disease control Not yet recruitingThis study tests whether a low-carbohydrate, plant-based diet can lower inflammation in people with autosomal dominant polycystic kidney disease (ADPKD). Thirty-six adults will try the special diet and their usual diet in random order, each for 12 weeks. The main goal is to see i…
Phase: NA • Sponsor: Assaf-Harofeh Medical Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Brain infusion upgrade: could a new method make Parkinson's treatment easier?
Disease control Not yet recruitingThis study tests a new, faster method to deliver the drug AB-1005 into the brain of people with advanced Parkinson's disease. The goal is to see if the new approach can consistently reach the target area while being safer and quicker. 18 participants will be enrolled to assess th…
Phase: PHASE2 • Sponsor: AskBio Inc • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can a special diet calm Crohn's Flare-Ups?
Disease control Not yet recruitingThis study tests whether a specially designed anti-inflammatory diet can reduce symptoms and gut inflammation in people with mild-to-moderate Crohn's disease. For 8 weeks, 122 participants will receive fully catered meals and weekly coaching from a dietitian. The goal is to see i…
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis early-stage trial tests an oral capsule containing a genetically modified probiotic yeast designed to neutralize toxins produced by C. diff bacteria. The study first evaluates safety in healthy adults, then in people at risk for recurrent C. diff infection. Participants take…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Real-World study to track Jivi's bleeding prevention in kids
Disease control Not yet recruitingThis observational study will follow 40 children aged 7 to 12 with hemophilia A who are already prescribed damoctocog alfa pegol (Jivi) to prevent bleeding. Researchers will collect data from routine care, including bleeding episodes and treatment patterns, over two years. The go…
Sponsor: Bayer • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Jaw vs. hip bone: which graft works best for cleft repair?
Disease control Not yet recruitingThis study compares two surgical techniques to repair a bone gap in the upper jaw (alveolar cleft) in 20 people who missed earlier treatment. One method uses bone from the patient's jaw, the other from the hip. Researchers will measure bone volume and shape after 6 months to see …
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug trial aims to protect Kids' kidneys from IgA nephropathy
Disease control Not yet recruitingThis phase 3 trial tests the drug atrasentan in 28 children aged 2 to 18 with IgA nephropathy, a kidney disease that can lead to kidney failure. The study measures whether atrasentan reduces protein in the urine, a sign of kidney damage, over 36 weeks. All participants receive th…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New study tests Anti-Inflammatory drug for Crohn's in china
Disease control Not yet recruitingThis study will test the drug Tabellvi (adalimumab) in 50 Chinese adults with moderate to severe Crohn's disease. The goal is to see how safe and effective it is in real-world settings, focusing on side effects and whether patients achieve remission after 26 weeks. Participants m…
Phase: PHASE4 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New clinic aims to cut COPD Flare-Ups in half
Disease control Not yet recruitingThis study tests whether a dedicated clinic for COPD flare-ups can reduce the number of future attacks and improve quality of life. About 240 people who recently had a severe COPD attack will be split into two groups: one gets follow-up at the special clinic, the other gets stand…
Phase: NA • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New pill may cut blood transfusions for kids with thalassemia
Disease control Not yet recruitingThis study tests a drug called mitapivat in children aged 1 to 17 with alpha- or beta-thalassemia who need regular blood transfusions. The goal is to see if mitapivat can reduce the number of transfusions needed compared to a placebo. The study involves 54 participants and lasts …
Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental CAR-T therapy takes on tough lupus cases
Disease control Not yet recruitingThis early-stage trial tests a new treatment called P-CD19CD20-ALLO1, a type of CAR-T cell therapy, for people with severe lupus that hasn't improved with standard treatments. The study will enroll 162 participants and aims to check if the therapy is safe and tolerable. It also l…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New pill aims to cut lung infections in bronchiectasis patients
Disease control Not yet recruitingThis phase 3 trial tests whether a daily tablet called florensocatib can reduce the number of lung flare-ups in people with bronchiectasis, a chronic lung condition. About 904 participants aged 12 to 85 will be randomly assigned to receive either the drug or a placebo for up to 7…
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New needle route may stop deadly bleeding in clogged portal veins
Disease control Not yet recruitingThis study tests a new procedure for people with a completely blocked main portal vein who have had at least two episodes of dangerous variceal bleeding. Doctors will use ultrasound to guide a needle into a vein in the gut, then try to reopen the blocked vein or create a new bypa…
Phase: NA • Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Ancient herbs meet modern medicine: can Curcumin-QingDai tame UC?
Disease control Not yet recruitingThis study tests whether adding a combination of curcumin (from turmeric) and QingDai (a traditional Chinese herb) to standard vedolizumab treatment can help people with moderate to severe ulcerative colitis reach remission. About 160 adults will receive either the herbal combo o…
Phase: PHASE4 • Sponsor: Ryan C Ungaro • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could extra antibiotics help prolong pregnancy after early water break?
Disease control Not yet recruitingThis pilot study tests whether adding extra doses of the antibiotic azithromycin to standard care can improve outcomes for pregnant people whose water breaks very early (between 22 and 28 weeks). Thirty participants will be randomly assigned to receive either the standard antibio…
Phase: PHASE4 • Sponsor: Alexa Henderson • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New team approach aims to simplify care for heart and kidney health
Disease control Not yet recruitingThis study tests a 6-month program where patients work with a pharmacist and their primary care doctor to make shared decisions about medications and lifestyle. The goal is to see if this team-based approach improves heart and kidney health scores and medication adherence. The st…
Phase: EARLY_PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Crohn's blockage showdown: drugs or surgery for better quality of life?
Disease control Not yet recruitingThis trial compares two approaches for people with Crohn's disease who have a narrowed section of the small bowel causing symptoms. One group receives a combination of two drugs (azathioprine and infliximab), while the other group undergoes surgery to remove the narrowed segment.…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Healing protein injection could ease back pain without surgery
Disease control Not yet recruitingThis study tests a new medicine called CBT005, a healing protein injected directly into damaged spinal discs. The goal is to see if it is safe and can reduce long-term back pain in 60 adults with disc degeneration. Participants get one injection and are followed for up to 3 years…
Phase: PHASE1, PHASE2 • Sponsor: Cartago Biotech Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Parkinson's patients test VR and brain games to steady their steps
Disease control Not yet recruitingThis study compares two types of cognitive-based balance training for people with Parkinson's disease: one using virtual reality (VR) and the other combining balance exercises with mental tasks like counting. Thirty-four participants aged 40-80 will do 16 sessions over 8 weeks. R…
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New blood test could prevent dangerous delays in preeclampsia deliveries
Disease control Not yet recruitingThis study tests whether a blood test measuring the sFlt-1/PlGF ratio can help doctors decide the best time to deliver babies in women with severe early-onset preeclampsia. The trial will include 386 pregnant women between 30 and 34 weeks of gestation. Half will have delivery tim…
Phase: NA • Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a pill cut transfusions for sickle cell patients?
Disease control Not yet recruitingThis Phase 3 trial tests whether the drug mitapivat can reduce the need for blood transfusions in people with sickle cell disease. About 159 participants aged 12 and older will receive either mitapivat or a placebo daily for a year. The main goal is to see if more people can avoi…
Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a Cholesterol-Lowering cream replace surgery for eyelid bumps?
Disease control Not yet recruitingThis study tests whether a cream containing simvastatin (a cholesterol-lowering drug) can safely shrink yellow cholesterol deposits on the eyelids, called xanthelasma. Thirty adults will apply either the active cream or a placebo nightly for 24 weeks, then everyone gets the activ…
Phase: PHASE2 • Sponsor: Klira Skin • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage trial tests a new drug called LY4152199 in about 215 adults with certain types of blood cancer (like follicular lymphoma or diffuse large B-cell lymphoma) that have already been treated. The drug is designed to help the body's immune cells attack the cancer. The …
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo shows promise for aggressive lymphoma
Disease control Not yet recruitingThis phase 2 trial tests whether adding the drug epcoritamab to standard chemotherapy (DA-EPOCH-R) helps people with high-risk Burkitt lymphoma. About 43 adults will receive the combination. The study will check how many complete at least three cycles of treatment and track overa…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Electric zaps to the gut could tame diabetes and fatty liver
Disease control Not yet recruitingThis study tests a procedure called pulsENDO that uses mild electric pulses to regenerate the lining of the duodenum (the first part of the small intestine). The goal is to improve blood sugar control and reduce fat buildup in the liver for people with type 2 diabetes and fatty l…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Denture cap showdown: which material saves more bone?
Disease control Not yet recruitingThis study will compare two materials used for the caps that attach dentures to dental implants: acetal resin and nylon. The goal is to see which one causes less bone loss around the implants and keeps gums healthier. Twenty-two people with no teeth in their lower jaw will be enr…
Phase: NA • Sponsor: Future University in Egypt • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Lung patients may soon do rehab from home via app
Disease control Not yet recruitingThis study tests whether a 12-week tele-pulmonary rehabilitation program, done at home via an app with a physiotherapist, helps people with chronic lung diseases start and stick with rehab better than going to a center. 90 patients will be randomly assigned to either remote rehab…
Phase: NA • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill could help kids with thalassemia fight anemia without transfusions
Disease control Not yet recruitingThis Phase 3 trial tests whether the drug mitapivat can improve anemia in children aged 1 to 17 with alpha- or beta-thalassemia who do not need regular blood transfusions. About 45 participants will receive either mitapivat or a placebo for 24 weeks. The main goal is to see if mi…
Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a Vitamin-Like pill protect the brains of people with down syndrome?
Disease control Not yet recruitingThis early-stage trial tests a supplement called MIB-626 (a form of NMN) in 24 adults with Down syndrome. The goal is to see if it is safe and can raise NAD+ levels, which may help protect against Alzheimer's disease. Participants take the pill or a placebo for 28 days and are mo…
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Radioactive drug targets hard-to-treat neuroendocrine tumors in early trial
Disease control Not yet recruitingThis phase 1 trial tests a radioactive drug called 211At-MABG in 16 adults with advanced neuroendocrine cancers, including pheochromocytoma and paraganglioma. The drug delivers radiation directly to cancer cells that show up on a special scan. The main goal is to see if the treat…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
AI city halls: could Robot-Run domes cure addiction and homelessness?
Disease control Not yet recruitingThis study will test whether living in a self-contained, AI-managed community (called a Microcity) can improve mental health and reduce addiction in adults with conditions like autism, ADHD, substance use disorders, and behavioral addictions. Up to 1 million participants will liv…
Phase: NA • Sponsor: Veterans Recovery Network Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Smart blood pressure cuffs could protect cancer patients from heart risks
Disease control Not yet recruitingThis pilot study tests whether a connected blood pressure monitor, supervised daily by a healthcare assistant, helps patients with blood cancers like CLL or lymphoma stick to home monitoring. The goal is to catch and manage high blood pressure early, a common side effect of BTK i…
Phase: NA • Sponsor: Centre Hospitalier de la côte Basque • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Tailored exercise may boost fat burning in women with PCOS
Disease control Not yet recruitingThis study investigates whether a supervised, adapted physical activity program can improve how the body burns fat during walking in women with overweight or obesity, both with and without polycystic ovary syndrome (PCOS). Researchers will compare changes in fat oxidation and oth…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New implant aims to ease stubborn back pain
Disease control Not yet recruitingThis study will test a titanium implant designed to fuse the sacroiliac joint in people with chronic lower back pain that hasn't responded to non-surgical treatments. About 120 adults with sacroiliac joint dysfunction will receive the implant and be followed for safety and pain r…
Sponsor: SI-BONE, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New trial combines HIV PrEP and STI prevention in one package for young men
Disease control Not yet recruitingThis study tests whether a combined approach—offering HIV PrEP (pills or injections) and STI prevention (doxycycline after sex) along with smartphone tools—helps young men at high risk stay protected. About 400 men aged 18-29 who have sex with men will be followed for a year to s…
Phase: PHASE3 • Sponsor: HIV Prevention Trials Network • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a cheap arthritis drug shield kidneys from heart and bone damage?
Disease control Not yet recruitingThis study tests whether a low dose of colchicine, a common anti-inflammatory drug, can slow down blood vessel hardening and bone problems in people with stage 3 chronic kidney disease. About 60 adults will take colchicine or receive usual care for 12 months. The goal is to see i…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Engineered immune cells take aim at Hard-to-Treat lupus
Disease control Not yet recruitingThis trial tests a one-time treatment called CAR-T cell therapy for people with systemic lupus erythematosus (lupus) that hasn't improved with standard medications. The therapy uses a patient's own immune cells, which are modified in a lab to find and destroy the B cells that dri…
Phase: PHASE1, PHASE2 • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New uganda trial tackles alcohol and HIV care for men with pregnant partners
Disease control Not yet recruitingThis pilot study tests a program called Kisoboka Amaka for men living with HIV who drink heavily and have pregnant partners. The program combines counseling, financial training, and mobile savings to help men drink less and take their HIV medication consistently. Researchers will…
Phase: NA • Sponsor: San Diego State University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Selective cell removal may tame stem cell Transplant's dangerous side effect
Disease control Not yet recruitingThis study tests whether removing a specific type of immune cell (naive T cells) from a donor's stem cell graft can prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the recipient's body. The trial enrolls people with non-malignant blood di…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New trial puts mirikizumab Head-to-Head with standard Crohn's therapy
Disease control Not yet recruitingThis study compares early treatment with mirikizumab (a biologic drug) to standard therapy with azathioprine plus steroids in 320 adults newly diagnosed with moderate-to-severe Crohn's disease. Participants are randomly assigned to one of two groups for 52 weeks. The goal is to s…
Phase: PHASE4 • Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New inhaled therapy aims to improve breathing in COPD patients
Disease control Not yet recruitingThis phase 3 study tests whether an inhaled medication called HSK39004 can improve lung function in people with moderate to severe chronic obstructive pulmonary disease (COPD). Participants receive either the drug or a placebo twice daily for 24 weeks. The main goal is to measure…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New weekly shot aims to turn back the clock on prediabetes
Disease control Not yet recruitingThis study tests whether a once-weekly injectable drug called mazdutide can help adults with prediabetes achieve normal blood sugar levels. About 150 participants will receive either a low dose, a higher dose, or a placebo for 24 weeks, along with diet and exercise advice. The ma…
Phase: PHASE4 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Nasal spray of stem cell 'Messages' could slow rare brain disease
Disease control Not yet recruitingThis study tests a new nasal spray treatment for frontotemporal dementia (FTD), a brain disease that changes personality and language. The spray contains tiny particles from umbilical cord stem cells that may protect brain cells and reduce harmful protein buildup. About 33 adults…
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could remote hand exercises ease Parkinson's symptoms?
Disease control Not yet recruitingThis study investigates whether upper extremity exercise training delivered via tele-rehabilitation (synchronous or asynchronous) can improve motor symptoms, hand dexterity, and daily living activities in people with Parkinson's disease. Participants will receive either remote or…
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Takhzyro under the microscope: Real-World safety check for rare swelling disease
Disease control Not yet recruitingThis study looks at how safe and effective Takhzyro is for teenagers and adults with hereditary angioedema (HAE) in everyday medical care in South Korea. HAE is a rare condition that causes sudden swelling under the skin or inside the body. The study will track side effects and h…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple pill shield HAE patients from Procedure-Triggered attacks?
Disease control Not yet recruitingThis trial tests whether the drug sebetralstat can prevent swelling attacks in people with hereditary angioedema (HAE) when taken before a medical procedure. Participants aged 12 and older with HAE type I or II will take sebetralstat just before their scheduled procedure. The mai…
Phase: PHASE4 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a stomach shield drug replace acid blockers for steroid users?
Disease control Not yet recruitingThis study tests whether teprenone, a stomach-protecting drug, can reduce gastrointestinal damage caused by high-dose steroids in people with lupus. One hundred participants will be randomly assigned to take either teprenone or the standard acid-blocker omeprazole for 12 weeks. T…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could cocoa and veggies protect against pregnancy complications?
Disease control Not yet recruitingThis trial investigates whether a diet rich in polyphenols—including daily cocoa and extra fruits and vegetables—can reduce oxidative stress and improve blood vessel function in pregnant women. Researchers will randomly assign 60 pregnant women to receive dietary counseling and c…
Phase: NA • Sponsor: University of Salamanca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Sauna therapy could slash antibiotic use in chronic lung disease
Disease control Not yet recruitingThis study tests whether frequent sauna baths can reduce or eliminate bacteria that cause stubborn lung infections in people with conditions like COPD, asthma, or bronchiectasis. Researchers will track how long participants go without needing antibiotics and whether the bacteria …
Phase: NA • Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common liver drug replace steroids for immunotherapy side effects?
Disease control Not yet recruitingThis phase 2 trial tests whether ursodeoxycholic acid (UDCA), a drug already used for other liver conditions, can treat cholestatic hepatitis—a liver inflammation caused by immunotherapy—better than standard steroids. About 94 adults with cancer (excluding liver cancer) who devel…
Phase: PHASE2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
One-Time gene injection aims to halt rare blindness
Disease control Not yet recruitingThis trial tests a single injection of a gene therapy called ZVS101e for people with Bietti crystalline dystrophy, a rare inherited eye disease that leads to progressive vision loss. The therapy uses a harmless virus to deliver a working copy of the CYP4V2 gene to cells in the ey…
Phase: NA • Sponsor: Chigenovo Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks safety of clotting drug for hemophilia patients in india
Disease control Not yet recruitingThis study looks at the safety and effectiveness of Octocog alfa, a lab-made clotting factor, when used to treat sudden bleeding episodes in adults with severe hemophilia A. About 33 people in India who have used factor VIII before will take part. Researchers will track side effe…
Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to shield autoimmune patients from Life-Threatening infections
Disease control Not yet recruitingThis study tests whether a medicine called Panzyga can prevent major infections in people with autoimmune or rheumatic conditions who have low antibody levels after receiving B-cell depletion therapy. About 360 adults will receive either Panzyga or a placebo, and researchers will…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New surgical trick may tame 'Rocky Hard' cataracts
Disease control Not yet recruitingThis study compares two surgical techniques for removing very hard cataracts, which are tough to break apart and can lead to complications like corneal swelling or lens rupture. The new method, called 'divide and conquer with debulking,' aims to make the procedure safer. Research…
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a stem cell shot before birth fix fanconi anemia?
Disease control Not yet recruitingThis early-phase trial tests whether giving healthy stem cells from the mother to a fetus diagnosed with Fanconi anemia can safely improve the baby's blood cell production. The treatment is a one-time injection into the fetus during pregnancy. The study will enroll 12 pregnant wo…
Phase: PHASE1, PHASE2 • Sponsor: Agnieszka Czechowicz • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to tame severe gut disease
Disease control Not yet recruitingThis study tests an experimental tablet called Hemay005 in 360 Chinese adults with moderate to severe ulcerative colitis, a chronic gut condition. Participants will receive either the drug or a placebo to see if it can bring about remission and improve symptoms over 12 weeks, wit…
Phase: PHASE3 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to lock in remission for rare lymphoma
Disease control Not yet recruitingThis study tests whether the drug elranatamab can help keep plasmablastic lymphoma, a rare and aggressive blood cancer, from returning after initial chemotherapy. About 17 adults with or without HIV who have already responded to first treatment will receive elranatamab injections…
Phase: PHASE2, PHASE3 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for cancer survivors: drug aims to shield against Life-Threatening infections
Disease control Not yet recruitingThis study tests a drug called IgPro20 in 63 adults who have a weakened immune system after receiving CAR T-cell therapy for blood cancers like lymphoma or multiple myeloma. The goal is to see if the drug can lower the number of serious bacterial infections, such as pneumonia or …
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New lens aims to sharpen sight after cataract removal
Disease control Not yet recruitingThis study tests a new artificial lens, called an intraocular lens (IOL), placed in the eye during cataract surgery. The lens is designed to replace the eye's natural lens and help restore vision. Researchers will measure how clearly participants see one year after surgery and ch…
Phase: NA • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Supercharging the Body's own defenses to fight Hard-to-Treat GIST
Disease control Not yet recruitingThis trial tests whether a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), can be grown in a lab and then given back to fight advanced gastrointestinal stromal tumors (GIST). The study includes people whose GIST has spread, come back, or cannot be remove…
Phase: PHASE2 • Sponsor: Joal Beane • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for kids with sanfilippo syndrome b?
Disease control Not yet recruitingThis early-stage trial tests a new drug called JR-446 in 12 children under 6 with MPS IIIB, a rare genetic disorder that damages the brain and body. The main goal is to see if the drug is safe and tolerable. Researchers will also measure changes in certain substances in the body …
Phase: PHASE1, PHASE2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a natural supplement calm ulcerative colitis?
Disease control Not yet recruitingThis study tests whether a supplement called palmitoylethanolamide (PEA) can help people with mild-to-moderate ulcerative colitis. Researchers will measure changes in disease activity, quality of life, and inflammation markers in 60 participants. The goal is to see if adding PEA …
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for SMA babies: boosting gene therapy with a Follow-Up drug
Disease control Not yet recruitingThis study tests a drug called salanersen in babies with spinal muscular atrophy (SMA) who have already received gene therapy. The drug aims to help the body make more SMN protein, which is needed for muscle function. About 42 babies with two copies of the SMN2 gene will be rando…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immunotherapy duo aims to shrink nasopharyngeal tumors before standard treatment
Disease control Not yet recruitingThis trial tests whether adding the immunotherapy drugs cemiplimab (with or without fianlimab) to standard chemotherapy before chemoradiation can improve outcomes for people with advanced nasopharyngeal cancer. About 60 adults with non-metastatic, EBV-positive nasopharyngeal carc…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to cut blood removal in rare cancer
Disease control Not yet recruitingThis trial tests rusfertide, an injected drug, in Japanese adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. The goal is to see if rusfertide can keep red blood cell levels under control and reduce the need for phlebotomy (blood removal). Al…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to treat leukemia without harsh chemo
Disease control Not yet recruitingThis study tests whether combining two drugs, inotuzumab and blinatumomab, is safe and effective for adults newly diagnosed with B-cell acute lymphoblastic leukemia (B-ALL). The trial includes 26 people aged 18 and older who are either 55+ or cannot tolerate standard chemotherapy…
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Laser zaps cysts: new study tests cheaper, faster fix
Disease control Not yet recruitingThis study compares two treatments for non-abscessed pilonidal cysts: a new laser fiber procedure and traditional surgery. Researchers will track costs, healing time, pain, and recurrence over 12 months in 150 adults. The goal is to see if laser treatment is more cost-effective a…
Phase: NA • Sponsor: Elsan • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug HBM7020 tested in humans for first time against autoimmune diseases
Disease control Not yet recruitingThis first-in-human study tests the safety of a new drug called HBM7020. It will first be given to healthy volunteers at low doses, then to people with moderate to severe autoimmune diseases like lupus, rheumatoid arthritis, scleroderma, and Sjögren's disease. The goal is to see …
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Fat cells injected into esophagus could tame reflux without surgery
Disease control Not yet recruitingThis pilot study tests whether injecting a patient's own fat-derived cells into the lower esophagus is safe and feasible for treating GERD that doesn't respond well to medication. Fifteen adults with chronic acid reflux will undergo a minimally invasive endoscopic procedure. The …
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New study could change how Men's UTIs are treated
Disease control Not yet recruitingThis study tests whether a common antibiotic for women's UTIs, fosfomycin-trometamol, works well for men with urinary tract infections. Current treatments can have serious side effects and increase antibiotic resistance. The trial will enroll 138 men in primary care and monitor f…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New inhaler hope for COPD patients in early trial
Disease control Not yet recruitingThis study tests a new inhaled drug called HRS-9821 in people with moderate to severe COPD. About 90 participants will receive either the drug or a placebo for 28 days. The main goal is to see if the drug improves lung function, measured by how much air they can exhale in one sec…
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New combo therapy aims to tame leukemia without lifelong pills
Disease control Not yet recruitingThis study tests whether combining dasatinib with ropeginterferon can better control chronic myeloid leukemia in its early phase. About 40 adults newly diagnosed with CML will receive the drug pair to see if it improves disease control and reduces side effects. The goal is to man…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New combo pill attack aims to control blood cancers
Disease control Not yet recruitingThis study tests two experimental drugs (rocbrutinib and lacutoclax) taken together to treat several types of blood cancers, including lymphoma and leukemia. The goal is to see if the combination is safe and can shrink or control the cancer. About 92 adults who have already tried…
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug BHV-1400 aims to protect kidneys in IgA nephropathy
Disease control Not yet recruitingThis Phase 3 trial tests whether BHV-1400 can safely reduce protein in the urine and preserve kidney function in 420 adults with IgA nephropathy. Participants are randomly assigned to receive either the drug or a placebo by injection. The main goal is to see if BHV-1400 lowers pr…
Phase: PHASE3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a lower dose of acne drug work just as well with fewer side effects?
Disease control Not yet recruitingThis study tests whether a low daily dose of the acne drug isotretinoin can clear moderate to severe acne as effectively as the standard dose, but with fewer side effects. About 164 people aged 18-45 will be randomly assigned to one of two dose groups. Researchers will track acne…
Phase: PHASE4 • Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a popular Weight-Loss drug help—or Harm—Those with duchenne muscular dystrophy?
Disease control Not yet recruitingThis study tests whether semaglutide (a GLP-1 drug used for weight loss) is safe for adolescents and young adults with Duchenne muscular dystrophy (DMD) who are also overweight or obese. The main concern is that the drug might reduce muscle mass, which is already weak in DMD. Par…
Phase: PHASE1, PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Weight-Loss drug wegovy tested as Hair-Pulling treatment
Disease control Not yet recruitingThis study tests whether a weekly injection of semaglutide (Wegovy), a drug used for weight loss and diabetes, can help people with trichotillomania (hair-pulling disorder). Ten adults aged 18-75 with daily hair pulling will receive the drug for several weeks. Researchers will me…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Promising drug combo targets aggressive brain cancers in youth
Disease control Not yet recruitingThis study is for adolescents and young adults (ages 12-39) newly diagnosed with aggressive brain tumors called high-grade glioma or DIPG. The goal is to see if a combination of two immunotherapy drugs (relatlimab and nivolumab, sold as Opdualag) is safe and tolerable when given …
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New injection aims to tackle high cholesterol in early human trial
Disease control Not yet recruitingThis early-stage trial tests a single injection of MWX205 in 37 adults with high cholesterol or blood fats (dyslipidemia). Researchers will check if the drug is safe, how the body processes it, and how it affects cholesterol levels compared to a placebo. The goal is to find the r…
Phase: PHASE1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New CAR-T therapy shows promise for tough leukemia in Real-World study
Disease control Not yet recruitingThis study will follow 200 Chinese patients with relapsed or refractory B-cell acute lymphoblastic leukemia who receive a CAR-T cell therapy called puzolcabtagene autoleucel. The goal is to see how well it works in everyday medical practice, measuring response rates and how long …
Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for kids with lymphoma: drug combo may replace harsh chemo
Disease control Not yet recruitingThis study tests a combination of two drugs, camrelizumab and ivarmacitinib, as a first treatment for children aged 6-18 with newly diagnosed classical Hodgkin lymphoma. The goal is to see if this approach can achieve a complete metabolic response (no signs of active cancer) whil…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could cord blood transfusions protect fragile preemies?
Disease control Not yet recruitingThis study tests whether using cord blood, rich in fetal hemoglobin, for transfusions in preterm infants can reduce serious complications like blindness, lung disease, and gut problems. Researchers will compare outcomes in 200 very low birth weight babies who receive either cord …
Phase: NA • Sponsor: University of Parma • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a common antibiotic ease Kids' bowel disease?
Disease control Not yet recruitingThis study tests whether oral vancomycin, an antibiotic, can help children aged 6-15 with inflammatory bowel disease (IBD), especially types linked to liver problems. About 140 kids will either get vancomycin plus standard care or standard care alone for up to a year. Researchers…
Phase: PHASE2 • Sponsor: Tampere University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Real-World check: Asciminib's performance in Tough-to-Treat CML
Disease control Not yet recruitingThis study will follow about 98 adults with chronic myeloid leukemia who are taking asciminib after other treatments have stopped working. Researchers want to see how many patients achieve a major molecular response (a key sign of disease control) after two years. The goal is to …
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could stem cell secretions tame tough Crohn's? new trial aims to find out
Disease control Not yet recruitingThis study tests a new treatment called DB-3Q for people with Crohn's disease that hasn't improved with standard therapies. DB-3Q is made from stem cells and may help reduce inflammation in the gut. The trial will enroll 36 adults and focus on safety and how well the treatment wo…
Phase: PHASE2 • Sponsor: Direct Biologics, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New combo therapy aims to outsmart leukemia with less poison
Disease control Not yet recruitingThis phase 2 trial is testing a new way to treat adults newly diagnosed with a specific type of acute lymphoblastic leukemia (Ph-negative B-ALL). Instead of standard high-dose chemotherapy, patients receive a mix of low-dose chemo plus several targeted drugs (inotuzumab ozogamici…
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Psoriasis patients: does your injection schedule matter?
Disease control Not yet recruitingThis study looks at 120 adults with moderate-to-severe psoriasis who take secukinumab, a biologic drug. It compares two maintenance schedules: the standard every-4-week injection versus a non-standard schedule (longer intervals or lower dose). The goal is to see which schedule ke…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for tough lymphoma: Three-Drug showdown begins
Disease control Not yet recruitingThis phase II trial tests whether a drug called mosunetuzumab works better alone or combined with either zanubrutinib or polatuzumab vedotin for people with marginal zone lymphoma that has returned or stopped responding to treatment. The study will enroll 138 participants and mea…
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New study tests best glasses for kids with wandering eyes and nearsightedness
Disease control Not yet recruitingThis study compares two types of special glasses (DIMS and DOT) to control nearsightedness in children aged 6 to 12 who also have intermittent exotropia (a type of eye misalignment). Researchers want to see which lens works better and whether the glasses affect eye coordination. …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New cortisol timing therapy may improve life for adults with rare hormone disorder
Disease control Not yet recruitingThis study follows 100 adults with congenital adrenal hyperplasia (CAH) who switch from standard steroids to a timed-release hydrocortisone (Efmody). The goal is to see if better mimicking the body's natural cortisol rhythm improves hormone levels, metabolic health, and quality o…
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Gene therapy hope for babies with fatal muscle disease
Disease control Not yet recruitingThis early-phase trial tests a gene therapy called SKG0201 in 11 infants with spinal muscular atrophy (SMA) type I, a severe muscle-weakening disease. The therapy uses a harmless virus to deliver a working copy of the missing SMN1 gene. The study aims to see if it is safe and can…
Phase: PHASE1, PHASE2 • Sponsor: Lanyue Biotech (Hangzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New combo aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThis study tests whether adding a new drug called revumenib to the usual treatment (blinatumomab plus chemotherapy) can better clear leftover leukemia cells in people with a specific genetic type of B-cell acute lymphoblastic leukemia (ALL) or mixed-lineage leukemia. About 90 adu…
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New psoriasis cream takes on old standby in Head-to-Head trial
Disease control Not yet recruitingThis study will test whether a newer cream called tapinarof works better than the standard betamethasone cream for mild-to-moderate plaque psoriasis. About 120 adults will use one of the two creams daily for up to 12 weeks. The main goal is to see how many people get at least a 7…
Phase: PHASE4 • Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
3D printed dentures face off against traditional milled ones in new trial
Disease control Not yet recruitingThis study compares two types of full dentures: 3D printed ones and milled ones. Researchers want to see which lasts longer and causes fewer problems over five years. Sixty-eight adults who need complete dentures will take part, and the main focus is how many dentures are still w…
Phase: NA • Sponsor: Dentsply Sirona Implants and Consumables • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a simple gel boost gum healing in diabetes?
Disease control Not yet recruitingThis study tests whether adding hyaluronic acid gel to standard deep cleaning (scaling and root planing) improves gum healing in people with both diabetes and advanced gum disease. Twenty-three participants will receive the standard cleaning on all teeth, and then two gum pockets…
Phase: NA • Sponsor: Marmara University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for Alzheimer's in down syndrome: drug trial launches
Disease control Not yet recruitingThis study tests a drug called mivelsiran in 58 adults with Down syndrome who have early-stage Alzheimer's. Participants receive either the drug or a placebo via injection into the spine every few months for two years. The goal is to see if the drug can reduce brain changes linke…
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Engineered immune cells take on aggressive lymphomas in new trial
Disease control Not yet recruitingThis study tests a new treatment called CD70.CAR NK cells for people with diffuse large B-cell lymphoma or Hodgkin lymphoma that did not respond to or came back quickly after initial therapy. The treatment uses specially designed immune cells from a donor to find and attack cance…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New COPD inhaler HSK39004 tested for Long-Term safety in 300 patients
Disease control Not yet recruitingThis study tests the long-term safety and effectiveness of an experimental inhaler called HSK39004 in 300 adults aged 40 to 80 with moderate-to-severe COPD. Participants will use the inhaler twice daily for 52 weeks. The main goal is to monitor side effects and see how well the t…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a protein boost make a PCOS supplement work better?
Disease control Not yet recruitingThis study compares myo-inositol alone versus myo-inositol plus alpha-lactalbumin in 82 women with PCOS who want to conceive. Over 12 weeks, researchers will track pregnancy rates, menstrual regularity, and metabolic changes. The goal is to see if adding alpha-lactalbumin improve…
Phase: NA • Sponsor: Quaid-e-Azam Medical College • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a special supplement boost health in cystic fibrosis?
Disease control Not yet recruitingThis study will test whether a nutrition supplement with different forms of certain nutrients works better than standard supplements for adults with cystic fibrosis. Sixty participants will take the supplement for six weeks, and researchers will measure nutrient levels in their b…
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Phone coaching and home monitoring aim to tame high blood pressure in women after preeclampsia
Disease control Not yet recruitingThis study tests whether a mobile health program—combining home blood pressure monitoring with virtual coaching—can help midlife women control high blood pressure after having had a hypertensive disorder of pregnancy (like preeclampsia). About 50 women who had such a pregnancy 10…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Brain training boosts shoulder rehab? new trial investigates
Disease control Not yet recruitingThis study tests whether adding brain-challenging exercises (like reacting to lights while moving) to standard physical therapy helps people recover better after shoulder stabilization surgery. Thirty-two adults who had surgery for shoulder instability will be randomly assigned t…
Phase: NA • Sponsor: Hacettepe University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Engineered immune cells aim to tame stubborn autoimmune diseases
Disease control Not yet recruitingThis early-stage trial tests a one-time infusion of donor immune cells (CAR-γδT cells) designed to target and destroy faulty B cells in people with severe autoimmune diseases like lupus and scleroderma. The main goal is to check safety and find the right dose in 9 adults whose di…
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug aims to stop nosebleeds in rare blood vessel disorder
Disease control Not yet recruitingThis study tests an experimental drug called ATV-1601 in people with moderate to severe HHT, a condition that causes frequent nosebleeds and anemia. The trial has two parts: first, participants receive either the drug or a placebo to check safety and effectiveness; then, all elig…
Phase: PHASE1, PHASE2 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for ulcerative colitis patients who failed biologics?
Disease control Not yet recruitingThis study tests an experimental drug called ATH-063 in 120 adults with moderate to severe ulcerative colitis who have not responded to or can no longer use biologic therapies. Participants will receive either the drug or a placebo for 12 weeks to see if it can reduce symptoms an…
Phase: PHASE2 • Sponsor: Athos Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New cocktail aims to wake up sleeping HIV
Disease control Not yet recruitingThis early-stage trial tests whether combining two drugs—ibalizumab and chidamide—can safely reduce the hidden HIV reservoir in people living with HIV. The study will enroll up to 29 adults on stable antiretroviral therapy. Researchers will monitor side effects and measure change…
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug cocktail aims to tame tough leukemias
Disease control Not yet recruitingThis study tests a combination of seven drugs (including asciminib and venetoclax) in 30 adults with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute myeloid leukemia. The first phase checks safety, and the second phase sees if the combo helps control t…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Smartphone app aims to reduce pregnancy risks from hypertension and diabetes
Disease control Not yet recruitingThis study tests whether a mobile app (MOM-HD) can help pregnant women with high blood pressure or diabetes monitor their blood pressure and blood sugar at home. About 864 women in Nepal will either use the app plus standard care or standard care alone. The goal is to see if home…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Real-World study tracks how long patients stick with gut disease drug
Disease control Not yet recruitingThis study observes 35 adults with moderate-to-severe Crohn's disease or ulcerative colitis to see how long they continue taking guselkumab in everyday medical practice. Researchers will track treatment persistence and early symptom relief, like reduced bowel urgency. No experime…
Sponsor: Janssen-Cilag Pharma GmbH • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a smartphone app help youth with HIV in the south stick with treatment?
Disease control Not yet recruitingThis study will test a mobile app called MindBodyU designed to help young people (ages 16-25) living with HIV in South Carolina stay connected to their care and take their HIV medication regularly. The goal is to see if the app is easy to use, liked by users, and helps improve me…
Phase: NA • Sponsor: University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New dissolving stent could spare kids repeated heart surgeries
Disease control Not yet recruitingThis trial tests a new type of stent that dissolves over time for children under 9 with narrowed arteries in or near the heart. The stent opens the vessel and then gradually disappears, allowing the artery to grow naturally. The study will enroll 45 children and follow them for 5…
Phase: NA • Sponsor: PediaStent LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug cevostamab enters early human testing for lupus
Disease control Not yet recruitingThis early-stage trial will test the safety and tolerability of a new drug, cevostamab, in 46 people with systemic lupus erythematosus, some of whom also have active lupus nephritis. The drug is given intravenously, and researchers will monitor side effects and how the drug moves…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a cancer drug boost social abilities in rare genetic condition?
Disease control Not yet recruitingThis study tests whether everolimus, a drug already approved for other conditions, can safely improve social abilities in people with PTEN Hamartoma Tumor Syndrome (PHTS). About 60 adults and children with PHTS and social difficulties will take either everolimus or a placebo for …
Phase: PHASE2, PHASE3 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New lupus drug tested in kids for first time
Disease control Not yet recruitingThis study tests anifrolumab, a drug already used in adults with lupus, in children aged 5 to 17. The goal is to see how the drug moves through the body and if it is safe. Twenty-four children with moderate to severe lupus will receive the drug as a shot under the skin, while con…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for angelman syndrome: drug trial targets brain function
Disease control Not yet recruitingThis study tests a drug called rugonersen, given via spinal injection, to see if it can improve thinking and communication skills in people with Angelman syndrome. The trial includes 165 children and adults aged 1 to 50. Researchers will compare the drug against a sham procedure …
Phase: PHASE3 • Sponsor: OHB Pediatrics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Promising new combo targets tough head and neck cancer
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs—becotatug vedotin (a targeted therapy) and pucotenlimab (an immunotherapy)—as a first treatment for advanced head and neck squamous cell carcinoma. It is for patients whose cancer has returned or spread and who cannot tolerate p…
Phase: PHASE2 • Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug cocktail targets tough leukemia
Disease control Not yet recruitingThis early-stage trial tests a new drug called LP-118 alongside standard treatments for adults newly diagnosed with Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). The study will enroll 26 people to find the safest dose and see if the combination helps control the d…
Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Experimental drug aims to boost energy in rare genetic disorders
Disease control Not yet recruitingThis study tests an oral drug called glycerol tributyrate in 24 adults with MELAS or LHON-Plus, two rare mitochondrial diseases that cause severe symptoms like strokes and vision loss. The trial is open-label (everyone gets the drug) and uses each person as their own control over…
Phase: PHASE1, PHASE2 • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New oral drug could tame overactive bone marrow in rare blood cancers
Disease control Not yet recruitingThis study tests a pill called selinexor in 15 adults with chronic blood cancers (MPN) whose blood cell counts are too high. The goal is to see if selinexor can safely bring those counts down and ease symptoms. Participants take the drug once a week for up to 3 months and are fol…
Phase: PHASE2 • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Smart blood test guides treatment for stubborn hodgkin lymphoma
Disease control Not yet recruitingThis study tests a combination of the immunotherapy drug pembrolizumab and three chemotherapy drugs (GVD) in 38 adults whose Hodgkin lymphoma returned or did not respond to one prior treatment. A special blood test (ctDNA) is used to see how well the treatment is working and to g…
Phase: PHASE2 • Sponsor: Michael Spinner, MD • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Gene therapy injection aims to tame Parkinson's symptoms
Disease control Not yet recruitingThis study tests a single injection of AB-1005 gene therapy directly into the brain for Japanese adults with moderate Parkinson's disease. The goal is to see if it is safe and can improve daily movement. Eight participants will be followed for 18 months.
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Hope for Huntington's: new drug aims to slow decline in major trial
Disease control Not yet recruitingThis study tests whether the drug pridopidine can slow the worsening of Huntington's disease (HD) in adults. About 400 participants will take either pridopidine or a placebo twice daily for one year, then everyone can receive pridopidine for two more years. The goal is to see if …
Phase: PHASE3 • Sponsor: Prilenia • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Hope for rare disease: new drug trial for VEXAS syndrome begins
Disease control Not yet recruitingThis study tests a drug called momelotinib in 136 adults with VEXAS syndrome, a rare inflammatory disease caused by a genetic mutation. The goal is to see if the drug can reduce disease activity, with participants receiving either momelotinib or a placebo. This is a phase 2/3 tri…
Phase: PHASE2, PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo pill aims to supercharge cholesterol lowering
Disease control Not yet recruitingThis Phase 3 trial tests whether a new combination pill containing laroprovstat and rosuvastatin lowers LDL cholesterol better than rosuvastatin alone. About 200 adults with high cholesterol and a history of heart disease or high risk will take either the combo or a placebo plus …
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo therapy aims to tackle tough bone cancer
Disease control Not yet recruitingThis study looks at whether giving radiation and chemotherapy together before surgery can help control high-risk Ewing sarcoma, a type of bone cancer. Researchers will follow 55 patients to see how well the treatment works and how safe it is. The goal is to improve local tumor co…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for immunotherapy side effects: blood filtering may replace steroids
Disease control Not yet recruitingThis study tests a treatment called extracorporeal photopheresis (ECP) for people with advanced melanoma who develop severe colitis or hepatitis from immunotherapy. ECP filters a patient's blood, treats it with a light-activated drug, and returns it to the body. The trial compare…
Phase: PHASE2 • Sponsor: Therakos LLC • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can an ultrasound replace a catheter for Kids' heart surgery planning?
Diagnosis Not yet recruitingThis study looks at 115 children aged 6 months to 5 years who have a hole in the heart (VSD) and need surgery. Doctors want to see if an ultrasound probe placed in the food pipe (TEE) can measure heart pressure as accurately as the standard method using a thin tube (catheter) ins…
Sponsor: Ain Shams University • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
AI eye scanner could speed up emergency referrals for vision loss
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence (AI) system can help eye doctors identify urgent retinal conditions—like retinal detachment or bleeding—more accurately from wide-field eye images. Eight ophthalmologists will review images with and without AI assistance to see …
Phase: NA • Sponsor: Xiamen Ophthalmology Center Affiliated to Xiamen University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New Pill-Sized device could prevent dangerous blockages during gut scans
Diagnosis Not yet recruitingThis study tests a special capsule that patients swallow to check if their intestines are clear enough for a standard camera capsule. About 25 people with known or suspected intestinal narrowing will take part. They will swallow the patency capsule and get an X-ray within 30 hour…
Phase: NA • Sponsor: AnX Robotica Corp. • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Spine surgeons test new CT technique to catch hidden instability during surgery
Diagnosis Not yet recruitingThis study looks at whether CT scans taken during lumbar spine surgery can detect spinal instability more reliably than standard X-rays taken before surgery. Researchers will review imaging and medical records from 100 adults undergoing surgery for degenerative spine conditions. …
Sponsor: 4th Military Clinical Hospital with Polyclinic, Poland • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
One scan to catch two silent threats: MRI may spot bone and muscle loss in kidney patients
Diagnosis Not yet recruitingThis study explores whether a single MRI fat-fraction (MRI-FF) scan can accurately diagnose osteoporosis and sarcopenia (muscle loss) in people with chronic kidney disease (CKD). Researchers will compare MRI-FF results with standard DXA scans in 868 participants—half with CKD and…
Sponsor: Capital Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Urine test may replace colonoscopy for colitis patients
Diagnosis Not yet recruitingThis study looks at whether a substance in urine, called PGE-MUM, can show if ulcerative colitis is active or in remission. Researchers will collect urine and blood samples from 114 adults with confirmed ulcerative colitis and compare the results with colonoscopy findings. If suc…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New PET tracer aims to spot Parkinson's in the brain
Diagnosis Not yet recruitingThis early-phase trial tests a new radioactive tracer called [11C]MODAG-005 that binds to abnormal protein clumps in the brain linked to Parkinson's disease and multiple system atrophy. Nine participants (patients with Parkinson's, MSA, and healthy volunteers) will receive the tr…
Phase: EARLY_PHASE1 • Sponsor: MODAG GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Handheld breath test could spot lung disease early
Diagnosis Not yet recruitingThis study evaluates a portable device that measures lung function using oscillometry—a technique that sends gentle sound waves into the lungs—to diagnose chronic respiratory diseases like COPD, asthma, and bronchiectasis. Researchers will enroll about 4,000 adults across 50 cent…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
New drug aims to stop deadly complication in leukemia therapy
Prevention Not yet recruitingThis study tests whether the drug Lisaftoclax can prevent differentiation syndrome (DS), a severe and sometimes life-threatening side effect, in people with acute promyelocytic leukemia (APL) who are receiving standard treatment. About 60 participants aged 16 and older will take …
Phase: PHASE2, PHASE3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New study tests whether extra support during pregnancy can prevent early delivery
Prevention Not yet recruitingThis study tests a personalized support program called PTBCARE+ for pregnant individuals at high risk of delivering early. The program includes a stress reduction toolkit, a website/app, care coordination, and optional massage. Researchers will compare stress levels and birth out…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Major trial tests if early aspirin stop is safe for Moms-to-Be
Prevention Not yet recruitingThis study looks at whether pregnant women at high risk for preeclampsia can safely stop taking daily aspirin at 24-28 weeks instead of continuing until 36 weeks. Over 15,000 women across Europe and Africa will be randomly assigned to stop or continue aspirin. The goal is to see …
Phase: PHASE3 • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Light therapy may shield kids with cancer from chemo mouth sores
Prevention Not yet recruitingThis study tests whether light therapy (photobiomodulation) can prevent mouth sores in children receiving chemotherapy. Fifty children aged 0-30 will receive daily light treatments during hospital stays and at home. Researchers will check if the therapy is easy to use and accepta…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Could a pacifier help babies with down syndrome breathe better at night?
Prevention Not yet recruitingThis study tests whether a special pacifier, called CURAPROX, can reduce the severity of obstructive sleep apnea (OSA) in infants with Down syndrome. Fifty infants will be enrolled at one month old, with half using the pacifier and half not. At six months, sleep tests will measur…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Double probe heat therapy may slash cervical cancer risk in HIV-positive women
Prevention Not yet recruitingThis study will test if using two heat probes instead of one can better prevent cervical cancer in 300 women with HIV in Zimbabwe. The standard single-probe treatment often fails in these women. The goal is to see if the two-probe method is safe, acceptable, and more effective at…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 13:08 UTC
-
New app aims to stop Parkinson's medication side effects before they start
Prevention Not yet recruitingThis study tests whether a smartphone app, called ICD-Shield, can help doctors adjust Parkinson's medications to prevent impulse control disorders (like compulsive gambling or shopping). About 528 people with early-stage Parkinson's will be randomly assigned to use the app or rec…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
New probe technique could slash cervical cancer risk in HIV-Positive women
Prevention Not yet recruitingThis study tests whether using two probes during a heat-based treatment (thermal ablation) works better than the usual one-probe method to prevent cervical cancer in women living with HIV. About 200 women aged 25-49 with HIV and cervical precancer will be enrolled. The goal is to…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
A simple chat or text could stop diabetes before it starts
Prevention Not yet recruitingThis pilot study tests whether a single, personalized conversation with a healthcare team member or a brief message through a patient portal can encourage adults with prediabetes to take action—like joining a diabetes prevention program or starting medication. Researchers will co…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
Texts and calls could save sight: pakistan study tests referral boost
Prevention Not yet recruitingThis study tests whether a structured referral tracking program helps adults in Pakistan complete follow-up eye care after community screenings. 500 participants will receive either standard referral or extra support like counseling and weekly reminders. The goal is to prevent bl…
Phase: NA • Sponsor: Health Services Academy, Islamabad, Pakistan • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
Media program aims to prevent suicide in nigerian men
Prevention Not yet recruitingThis study tests a new media-based program called CONSCIOUS to help men in Nigeria recognize symptoms of mental health issues like anxiety and suicide risk, and encourage them to seek support. The program uses videos or other media to reduce stigma and improve help-seeking. 74 me…
Phase: NA • Sponsor: Teesside University • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
Smartphone therapy may ease anxiety for those with disabilities
Symptom relief Not yet recruitingThis study tests whether a mobile app that combines digital cognitive behavioral therapy (CBT) with personal mental health coaching can reduce anxiety in adults with hearing or mobility disabilities. Participants use either the active program or a sham version for 8 weeks, with f…
Phase: NA • Sponsor: Toivoa Inc • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Sugar solution may rival steroids for stuck fingers
Symptom relief Not yet recruitingThis study compares two ultrasound-guided injections for trigger finger, a condition where a finger gets stuck in a bent position. One injection uses betamethasone (a steroid), the other uses dextrose (a sugar solution). The goal is to see if dextrose, which may help tissue heal,…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
VR headset beats Pre-Surgery jitters in new trial
Symptom relief Not yet recruitingThis study tests whether a virtual reality (VR) session the day before gallbladder surgery can lower patients' anxiety and uncertainty about general anesthesia. Two hundred adults who have never had anesthesia will either watch a VR video showing the operating room and anesthesia…
Phase: NA • Sponsor: Mackay Memorial Hospital • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Virtual reality may soothe teen anxiety during clinic visits
Symptom relief Not yet recruitingThis study tests whether a 15-20 minute virtual reality (VR) relaxation session can reduce anxiety in adolescents aged 12 to 18 during a primary care visit. Participants use the Healthy Mind® VR platform to explore calming environments like beaches or mountains while doing guided…
Phase: NA • Sponsor: Mohammed Bin Rashid University of Medicine and Health Sciences • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Pinhole contact lens aims to sharpen sight for two eye conditions
Symptom relief Not yet recruitingThis early study tests a special contact lens that has a tiny pinhole built in. The idea is that the pinhole helps focus light better, improving vision for people with presbyopia (age-related blurry near vision) or keratoconus (a cone-shaped cornea). Sixteen adults will try the l…
Phase: NA • Sponsor: Azalea Vision • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can a smartphone app help tame IBD symptoms?
Symptom relief Not yet recruitingThis pilot study will test a 24-week digital self-management program designed to help people with inflammatory bowel disease (IBD) manage their symptoms and build long-term healthy habits. The program is accessed via web or mobile device and is used alongside standard care. The s…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Magnetic pulses to the brain may tame OCD symptoms
Symptom relief Not yet recruitingThis study tests whether a device that sends magnetic pulses to a specific brain area (dorsomedial prefrontal cortex) can safely reduce obsessive-compulsive behaviors in adults aged 22 and older. Participants receive either real or sham stimulation over six visits. The main goal …
Phase: NA • Sponsor: BTL Industries Ltd. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a video call replace the physio clinic for neck pain?
Symptom relief Not yet recruitingThis study tests whether doing physiotherapy at home through live video calls works as well as going to a clinic for people with moderate neck pain from cervical spondylosis. Fifty-two adults aged 45-64 will be split into two groups: one gets in-person sessions, the other gets re…
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Ear nerve zaps may lift depression in Parkinson's
Symptom relief Not yet recruitingThis study tests whether a small device that gently stimulates a nerve in the ear can help reduce depression in people with Parkinson's disease. Participants use the device at home twice a day for 14 days. The trial measures changes in mood and brain activity to see if this simpl…
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Tuning in to relief: music therapy app tested for sickle cell pain
Symptom relief Not yet recruitingThis study will test whether a 4-week daily music therapy app can reduce chronic pain and improve quality of life in 25 youth with sickle cell disease. Participants will either use the app or receive standard educational materials. Researchers will also look at changes in immune …
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a phone app lift depression? small study aims to find out
Symptom relief Not yet recruitingThis pilot study will test whether a mobile phone app can help reduce depression symptoms in African American adults. Eight participants will attend six weekly 90-minute classes through the app and complete surveys over four months. The goal is to see if this approach is effectiv…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
A simple video before surgery may ease nerves — no pills needed
Symptom relief Not yet recruitingThis study tests whether watching a short educational video before surgery can lower anxiety in adults having elective procedures. Participants are randomly assigned to receive the video via a QR code they scan on their own phone, via a tablet provided in the waiting area, or to …
Phase: NA • Sponsor: Aksaray University Training and Research Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New study tests which laser technique clears kidney stones faster
Symptom relief Not yet recruitingThis study compares two ways to break up kidney stones using a laser and a suction device. One method turns stones into dust, the other into small fragments. The goal is to see which leaves fewer stone pieces behind after one month. About 86 adults with small kidney stones will t…
Phase: NA • Sponsor: Bir Hospital • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Nasal fentanyl spray could ease painful eye exams for premature babies
Symptom relief Not yet recruitingThis trial tests whether a fentanyl nasal spray can reduce pain during eye exams for retinopathy of prematurity (ROP) in preterm infants. About 58 babies born at or before 31 weeks will receive either fentanyl or a saltwater placebo before their routine exam, along with standard …
Phase: PHASE1, PHASE2 • Sponsor: Marsha Campbell-Yeo • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Virtual reality tested as a calming tool during chemo
Symptom relief Not yet recruitingThis study tests whether using a virtual reality headset with guided imagery—like calming nature scenes and breathing exercises—can reduce pain, anxiety, and fatigue in women with breast cancer during chemotherapy. Participants are randomly assigned to either receive VR-guided im…
Phase: NA • Sponsor: Thoalfokar Mohammed Al-Obaidi • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can a smartphone app help stroke survivors feel better?
Symptom relief Not yet recruitingThis study tests a mobile app called Maya that teaches cognitive behavioral therapy skills to adults who recently had a stroke and feel depressed or anxious. Ten participants will use the app for a few weeks to see if it is easy to use and helps improve their mood. The goal is to…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can a new skincare trio beat acne? virtual trial seeks answers
Symptom relief Not yet recruitingThis virtual clinical trial will test whether GenLabs' Social Skin products—a cleanser, serum, and cream—can improve acne symptoms and help skin heal better than a placebo. About 150 healthy adults aged 18 to 65 with acne will use the products for 30 days. The main goal is to see…
Phase: NA • Sponsor: GenCanna Acquisition Corp • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a simple nerve block transform heart surgery recovery?
Symptom relief Not yet recruitingThis study tests whether injecting a local anesthetic near the stellate ganglion in the neck, guided by ultrasound, can improve how patients feel after heart surgery. The block temporarily calms part of the nervous system, which may reduce pain, improve sleep, and lower the risk …
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Wearable device aims to unfreeze gait in Parkinson's
Symptom relief Not yet recruitingThis study tests whether a wearable device called cueStim can shorten the duration of freezing of gait—a sudden inability to move—in people with Parkinson's disease. About 60 participants, aged 60 to 90, will wear the device for four weeks during daily life and be assigned to one…
Phase: NA • Sponsor: Fortis Medical Devices Limited • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Hypnosis as a hospital treatment for gut disorders?
Symptom relief Not yet recruitingThis pilot study compares recorded gut-directed hypnosis to an educational recording for hospitalized patients with chronic gut problems, such as irritable bowel syndrome or inflammatory bowel disease. Participants listen to the recordings over the phone while in the hospital for…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Hands-On osteopathic moves may calm anxious minds, small trial hints
Symptom relief Not yet recruitingThis study tests whether a set of four gentle osteopathic manual techniques can reduce stress and anxiety in young adults aged 18 to 35. Thirty participants will either receive the real techniques or a placebo simulation, and researchers will measure changes in heart rate variabi…
Phase: NA • Sponsor: Escola Superior de Tecnologia da Saúde do Porto • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could a VR headset ease sickle cell pain?
Symptom relief Not yet recruitingThis study explores whether using a virtual reality headset can help reduce pain for adults with sickle cell disease during a painful crisis. Participants will try different types of headset experiences—like watching a 2D video or exploring a 3D world—during their infusion center…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Magic mushroom compound tested for Parkinson's depression
Symptom relief Not yet recruitingThis phase 2 trial tests whether a single dose of psilocybin, the active ingredient in magic mushrooms, can improve depression in people with Parkinson's disease. Forty participants will receive a low to high dose with psychological support. The study measures changes in depressi…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Virtual reality could replace pills for procedure pain
Symptom relief Not yet recruitingThis study tests whether using a virtual reality headset (HypnoVR) during interventional radiology procedures can lower patients' anxiety and pain. Seventy adults will be randomly assigned to either use the VR headset or receive standard care. Researchers will measure anxiety wit…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New therapy aims to help kids with speech disorder speak in phrases
Symptom relief Not yet recruitingThis study tests a speech therapy called DTTC-Connect for children aged 3 to 12 with childhood apraxia of speech, a disorder that makes it hard to say words clearly. The therapy focuses on helping children move from saying single words to speaking in phrases. Sixty-eight children…
Phase: NA • Sponsor: New York University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can a Weight-Loss drug ease rett syndrome?
Symptom relief Not yet recruitingThis Phase 3 trial tests whether fenfluramine (Fintepla) can reduce behavioral and emotional symptoms in people with Rett syndrome. About 200 participants will receive either the drug or a placebo for 14 weeks. The study measures changes in behavior, sleep, and overall condition …
Phase: PHASE3 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New 3D-Printed cage could ease anxiety during eye surgery
Symptom relief Not yet recruitingThis study tests a 3D-printed 'oxygen support cage' placed over the patient's head during cataract surgery. The cage lifts surgical drapes off the face, which may reduce feelings of suffocation and anxiety. Researchers will measure changes in blood pressure, heart rate, breathing…
Phase: NA • Sponsor: Ataturk University • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could a gentle zap to the brain ease Parkinson's symptoms?
Symptom relief Not yet recruitingThis study will test whether a gentle, non-invasive brain stimulation technique called tDCS can improve verbal fluency, thinking, and motor control in people with Parkinson's disease. Twenty participants aged 50-90 with Parkinson's and a verbal fluency deficit will receive the st…
Phase: NA • Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a 2-Hour online class ease IBD pain?
Symptom relief Not yet recruitingThis study tests two online pain education programs for adults with Crohn's disease or ulcerative colitis who have chronic pain. Participants will complete a 2-hour online session and report their pain and quality of life weekly for 8 weeks. The goal is to see if these programs a…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
New home rehab could transform COPD care
Symptom relief Not yet recruitingThis study tests a home-based pulmonary rehabilitation program for people with COPD. Participants will follow video-guided exercises, track their daily steps, and receive weekly health coaching. The goal is to improve quality of life, reduce breathlessness, and encourage a more a…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can special exercises help babies with torticollis move better?
Symptom relief Not yet recruitingThis study tests whether weight shift training—a type of physical therapy—can help infants with congenital muscular torticollis (a tight neck muscle that causes head tilting) bear weight more evenly on their arms. Thirty infants aged 6 to 12 months will be randomly assigned to re…
Phase: NA • Sponsor: Sahmyook University • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
AI chatbot coaches teens through anxiety homework
Symptom relief Not yet recruitingThis study tests BraveBot, a computer program that talks with young people (ages 12-22) through their phone or computer while they do exposure therapy homework for anxiety or OCD. BraveBot does not replace the therapist but offers real-time coaching and encouragement during assig…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Can a phone app help RA patients feel less anxious?
Symptom relief Not yet recruitingThis study tests whether an 8-week program of yoga and meditation delivered through a mobile app can reduce anxiety in adults with stable rheumatoid arthritis. About 100 participants will either use the app daily or continue with standard care. Researchers will measure changes in…
Phase: NA • Sponsor: Tugba Civi Karaaslan • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Numbing injection may ease pain after incontinence surgery
Symptom relief Not yet recruitingThis study tests whether injecting a numbing medicine (bupivacaine) into the surgical site during sling surgery for stress urinary incontinence can reduce pelvic and thigh pain after the operation. Sixty women will be randomly assigned to receive either the numbing medicine or a …
Phase: NA • Sponsor: Hadassah Medical Organization • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Your phone could soon sense when you're down and offer help — study tests app for early psychosis
Symptom relief Not yet recruitingThis study will test whether smartphone sensors can detect when someone with early psychosis is feeling anxious or depressed and then offer a short mindfulness or psychoeducation exercise. Ten adults aged 18–50 with early psychosis and mild mood symptoms will use the app for 10 w…
Phase: NA • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Could a bone drug ease pain in kids with rare inflammatory disease?
Symptom relief Not yet recruitingThis study tests whether the drug zoledronate can reduce pain in children aged 4 to 17 with chronic recurrent multifocal osteomyelitis (CRMO), a rare auto-inflammatory bone disease. The 30 participants have not responded to standard anti-inflammatory drugs. They will receive eith…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Mindfulness app may soothe heartburn and anxiety in GERD patients
Symptom relief Not yet recruitingThis study tests whether an 8-week online mindfulness program can reduce emotional distress and reflux symptoms in 500 adults with gastroesophageal reflux disease (GERD). Participants are randomly assigned to either the mindfulness program or usual care. The goal is to see if lea…
Phase: NA • Sponsor: Xinghua Liu • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Breathing training may ease acid reflux without drugs
Symptom relief Not yet recruitingThis study tests whether a daily breathing exercise program can reduce symptoms and improve quality of life in people with non-erosive reflux disease (NERD). Sixty participants will either do high-resistance breathing exercises or a sham version with no resistance for 8 weeks. Re…
Phase: NA • Sponsor: Izmir University of Economics • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a common muscle relaxant cut narcotic use after hysterectomy?
Symptom relief Not yet recruitingThis study tests whether adding cyclobenzaprine, a muscle relaxant, to standard pain medicines (ibuprofen, acetaminophen, and short-term narcotics) improves pain control and reduces narcotic use after minimally invasive hysterectomy. About 36 women undergoing laparoscopic hystere…
Phase: PHASE4 • Sponsor: Christiana Care Health Services • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Can a video rehab program help COPD patients in the countryside?
Symptom relief Not yet recruitingThis study tests whether a 12-week remote group rehabilitation program, done via video calls and a smartphone app, can help COPD patients living in remote areas start and stick with rehab. It compares this approach to standard in-person rehab. The goal is to see if the remote opt…
Phase: NA • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a simple infusion after bowel surgery cut opioid use and speed recovery?
Symptom relief Not yet recruitingThis study tests whether giving a drug called dexmedetomidine for 48 hours after laparoscopic bowel surgery helps patients recover better. About 70 adults will receive either the drug or a placebo, and neither they nor their doctors will know which. The main goal is to see if the…
Phase: PHASE3 • Sponsor: Dr. Naveed Siddiqui • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New radiofrequency device could ease Post-Burn hand pain
Symptom relief Not yet recruitingThis study tests whether TECAR therapy, a device that uses radiofrequency energy to heat tissues, can reduce pain and improve hand function in people with carpal tunnel syndrome after a burn. Fifty-two adults aged 20 to 40 with mild to moderate carpal tunnel and a history of uppe…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Sound waves aim to ease stuttering in early trial
Symptom relief Not yet recruitingThis study tests whether low-intensity focused ultrasound (LIFU), a gentle sound wave technique, can safely improve speech fluency in people who stutter. Twenty adults who stutter will receive LIFU or a sham treatment, and researchers will measure changes in stuttering severity a…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Talking therapy could help thalassemia patients take their meds
Symptom relief Not yet recruitingThis study tests whether motivational interviewing, a type of counseling, can help adults with beta-thalassemia major follow their iron chelation therapy more consistently. Forty-five participants in Oman will receive three one-on-one sessions with a nurse over six to eight weeks…
Phase: NA • Sponsor: Oman Ministry of Health • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Simple QR code video may ease ICU family anxiety
Symptom relief Not yet recruitingThis study tests whether giving family members of ICU patients a QR code that links to an educational video can improve their understanding of the ICU and reduce their anxiety. Participants are randomly assigned to receive either standard verbal information or the same informatio…
Phase: NA • Sponsor: Elazıg Fethi Sekin Sehir Hastanesi • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Zoom therapy aims to break barriers for deaf individuals seeking mental health help
Symptom relief Not yet recruitingThis study tests a two-session Zoom-based therapy designed to change beliefs about mental health treatment in Deaf adults who are not currently in care. Researchers will compare those who receive the therapy to a waitlist group to see if it increases treatment-seeking and reduces…
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Parkinson's patients may move better with music therapy
Symptom relief Not yet recruitingThis pilot study will test whether active music therapy (with a therapist) or passive music therapy (just listening to music) can improve exercise ability and motivation in 28 people with Parkinson's disease. Participants will do sit-to-stand and walking tests while receiving mus…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Could a gentle vibration treatment ease carpal tunnel pain?
Symptom relief Not yet recruitingThis study investigates whether matrix rhythm therapy, a device that delivers gentle vibrations to the hand and arm, can reduce symptom severity and improve hand function in people with mild-to-moderate carpal tunnel syndrome. Participants receive either active or sham therapy tw…
Phase: NA • Sponsor: Izmir Bakircay University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Mind-Body therapies tested to calm anxiety in childhood cancer survivors
Symptom relief Not yet recruitingThis study looks at whether adding hypnosis or relaxation sessions to standard psychological care can lower anxiety in children, teens, and young adults who have finished treatment for pediatric cancer. About 558 participants aged 7 to 25 who are in remission and have anxiety wil…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a smartphone app ease the Gut-Brain struggle for IBD patients?
Symptom relief Not yet recruitingThis study tests a mobile app designed to help Black and Hispanic adults with inflammatory bowel disease (IBD) manage stress and improve their quality of life. The app teaches coping skills, mindfulness, and disease acceptance. Researchers want to see if the app is practical and …
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
VR headsets could replace pills for surgery anxiety
Symptom relief Not yet recruitingThis study tests whether using virtual reality (VR) for mindfulness can help people feel less anxious and experience less pain during minor vascular surgery done under local anesthesia. 160 adults with varicose veins will be randomly assigned to either wear VR glasses with guided…
Phase: NA • Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a zap on the forehead ease Parkinson's shuffling?
Symptom relief Not yet recruitingThis study tests whether a non-invasive device that gently stimulates a nerve on the forehead (external trigeminal nerve stimulation, or eTNS) can immediately improve walking and other movement problems in people with Parkinson's disease. Thirty participants will each try two dif…
Phase: NA • Sponsor: Zhengli Di • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Braces breakthrough? new study tests two ways to move teeth faster
Symptom relief Not yet recruitingThis study compares two techniques to speed up the movement of upper canine teeth during orthodontic treatment: micro-osteoperforation (creating tiny holes in the jawbone) and photobiomodulation (low-level laser therapy). 75 people needing premolar extractions as part of braces w…
Phase: NA • Sponsor: Kufa University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a magnetic helmet and exercise help Parkinson's patients walk better?
Symptom relief Not yet recruitingThis study tests whether combining a painless brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) with balance exercises can improve walking and balance in people with Parkinson's disease. Twenty participants aged 40-80 will receive the combined…
Phase: NA • Sponsor: Chung Shan Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could hand therapy replace surgery for carpal tunnel?
Symptom relief Not yet recruitingThis study tests if a combination of manual therapy and nerve stimulation can relieve symptoms of moderate carpal tunnel syndrome as well as surgery recovery does. About 150 adults aged 30-50 with confirmed moderate carpal tunnel will be split into two groups: one gets the non-su…
Phase: NA • Sponsor: Universidad Europea de Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Which lens is best for cataract patients? new study aims to find out
Symptom relief Not yet recruitingThis study compares two types of artificial lens implants used in cataract surgery: the Clareon TruPlus and the Tecnis Eyhance. Researchers want to see which lens gives better vision at different distances and how satisfied patients are. The study involves 70 adults with cataract…
Sponsor: Gainesville Eye Associates • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
App-Based workouts could ease PCOS symptoms, small trial hopes
Symptom relief Not yet recruitingThis study tests whether an 8-week exercise program done through a digital platform can improve symptoms of polycystic ovary syndrome (PCOS) in women aged 18-40. Participants will be split into three groups: digital exercise, in-person exercise, or general physical activity advic…
Phase: NA • Sponsor: Biruni University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple water pill get moms home faster after severe preeclampsia?
Symptom relief Not yet recruitingThis study tests whether a common water pill (furosemide) can help women with severe preeclampsia recover faster after childbirth and leave the hospital sooner. About 186 women will receive either furosemide or a placebo starting 12 hours after delivery. The goal is to see if the…
Phase: PHASE2 • Sponsor: Universidad Nacional Autonoma de Honduras • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Which sedative is safer and more satisfying for moms during C-Section?
Symptom relief Not yet recruitingThis trial tests two sedatives—remimazolam and dexmedetomidine—to see which better relieves anxiety while keeping pregnant women comfortable and safe during spinal anesthesia placement for scheduled C-sections. The study includes 150 women at full term and measures success by pat…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
No-Cost trick to ease Kids' needle pain: tapping or humming during blood draws
Symptom relief Not yet recruitingThis study tests two simple, no-cost methods to reduce pain and fear in children aged 6-12 during blood draws: rhythmic skin tapping by a nurse just above the needle site, and the child humming an 'mmmm' sound. Both techniques are based on the idea that touch and vibration can pa…
Phase: NA • Sponsor: Akdeniz University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Peer navigators aim to close mental health gap for veterans of color
Symptom relief Not yet recruitingThis study tests a 12-week telehealth program called PARTNER-MH, where trained peer specialists help minoritized veterans navigate mental health care, address social needs, and improve communication with clinicians. The trial will enroll 268 veterans with depression, anxiety, or …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Dry eye gel may sharpen cataract surgery results
Symptom relief Not yet recruitingThis study looks at whether a gel-like filler placed in the tear ducts can improve dry eye symptoms and make eye measurements more accurate before cataract surgery. About 65 adults with dry eye disease will be observed. The goal is to see if treating dry eye first leads to better…
Sponsor: The Eye Institute of West Florida • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Foot rubs for migraines? new study tests if reflexology eases pain and anxiety
Symptom relief Not yet recruitingThis study will test whether foot reflexology—a type of foot massage—can help women aged 18-45 with migraines feel less pain, anxiety, and fear of movement. Twenty women will either receive 10 foot massage sessions over 5 weeks or no massage. Researchers will measure changes in h…
Phase: NA • Sponsor: Karabuk University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Sound waves instead of needles: new device targets back pain without piercing skin
Symptom relief Not yet recruitingThis trial investigates whether a device called Neurolyser XR can safely ease low back pain caused by sacroiliitis (inflammation of the joint at the base of the spine). The device uses high-intensity focused ultrasound to block pain signals from the joint, without needles or cutt…
Phase: NA • Sponsor: Federico II University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Needle instead of knife: new hernia repair studied
Symptom relief Not yet recruitingThis study tests a new way to fix hernias using a needle guided by ultrasound, avoiding large cuts and general anesthesia. It is for adults who cannot or do not want standard surgery. About 30 people will be followed for 8 months to see if the procedure is safe and improves quali…
Phase: NA • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a VR app ease the pain of sickle cell disease? new study aims to find out
Symptom relief Not yet recruitingThis study tests a virtual reality app called Amani designed to help adults with sickle cell disease manage pain, emotional distress, and social isolation. Researchers will enroll 40 adults to see if the app is easy to use and helpful for improving coping skills and peer support.…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can a smartphone app ease burnout in overworked doctors?
Symptom relief Not yet recruitingThis pilot study will test whether a 6-week app-based mental fitness program can improve wellbeing and self-compassion in anesthesiology residents. Sixty residents will be randomly assigned to either the mental fitness app or a control program. The main goal is to see if such a p…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Freezing pain away: yale tests Nerve-Blocking procedure for Long-Term relief
Symptom relief Not yet recruitingThis study will follow 80 people with chronic pain (like back, hip, or nerve pain) who are getting a procedure called cryoneurolysis, which uses cold to temporarily block pain signals. Researchers want to see if it leads to meaningful pain relief and better daily function over 12…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Ancient needle trick could ease stubborn neck pain without pills
Symptom relief Not yet recruitingThis study tests whether a specialized acupuncture technique called 'Three-Needle Dazhui' combined with electroacupuncture can reduce pain and improve daily function better than standard electroacupuncture alone. The trial will involve 74 adults with cervical spondylotic radiculo…
Phase: NA • Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Virtual therapy shows promise for Parkinson's balance
Symptom relief Not yet recruitingThis study will test whether a special exercise program called LSVT BIG, done via video calls at home, works as well as the same program done in a clinic. Forty people with mild-to-moderate Parkinson's disease will be randomly assigned to either remote or in-person therapy for 4 …
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Could a 4-Day therapy tame OCD? new study aims to find out
Symptom relief Not yet recruitingThis study tests a four-day intensive therapy called Bergen Four-Day Treatment (B4DT) for people with obsessive-compulsive disorder (OCD). About 35 patients will receive the therapy, which involves exposure and response prevention exercises over four days, followed by three month…
Phase: NA • Sponsor: Tampere University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Could a sleep aid also ease Parkinson's movement problems?
Symptom relief Not yet recruitingThis study tests whether the sleep medication lemborexant can improve both sleep and motor symptoms in people with Parkinson's disease. Forty-four participants will take either lemborexant or a placebo nightly for 28 days. Researchers will measure changes in sleep quality and mov…
Phase: PHASE4 • Sponsor: YangPan • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Zapping the brain to steady Parkinson's tremors and steps
Symptom relief Not yet recruitingThis study tests whether a non-invasive brain stimulation technique called temporal interference stimulation can improve tremor and walking difficulties in people with Parkinson's disease. Fifty participants will be randomly assigned to receive either real or sham stimulation dai…
Phase: NA • Sponsor: YangPan • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New study: simple exercises may close Post-Baby tummy gap
Symptom relief Not yet recruitingThis study looks at whether a 6-week exercise program can help new mothers with diastasis recti, a condition where the belly muscles separate after pregnancy. About 30 women, 6 to 12 weeks after giving birth, will either do the exercises or receive standard care. Researchers will…
Phase: NA • Sponsor: University of Vigo • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Could valbenazine ease OCD symptoms? new trial aims to find out
Symptom relief Not yet recruitingThis study tests whether valbenazine can safely reduce symptoms in adults with moderate-to-severe obsessive-compulsive disorder (OCD). About 30 participants will receive either the drug or a placebo in a crossover design, meaning everyone gets both over time. The main goal is to …
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Robots take on fragile pelvis fractures in the elderly
Symptom relief Not yet recruitingThis study compares two surgical methods for treating unstable pelvic fractures in people aged 60 and older with osteoporosis. Half of the 88 participants will receive robot-assisted minimally invasive screw placement, while the other half will have conventional open surgery. The…
Phase: NA • Sponsor: Junbo Liang • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a special diet tame ulcerative colitis? breath tests may tell
Symptom relief Not yet recruitingThis study tests whether a short liquid diet followed by a low-sulfur eating plan is safe and helpful for people with mild to moderate ulcerative colitis. Researchers will check if this approach improves gut health, lowers inflammation, and eases symptoms. They will also use brea…
Phase: NA • Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Wearable robot arm and smart bracelet aim to boost movement in stroke and Parkinson's
Symptom relief Not yet recruitingThis study will test a comfortable, soft elbow brace that helps bend and straighten the arm, along with a vibrating forearm bracelet that gives touch cues. About 45 people with stroke or Parkinson's disease will try these devices during arm exercises. The goal is to see if the de…
Phase: NA • Sponsor: IRCCS San Raffaele Roma • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can computer games clear the fog? new study tests brain training for ME/CFS
Symptom relief Not yet recruitingThis study compares two brain-training programs for adults with ME/CFS who experience brain fog. Both programs include computer games and a mild nerve stimulation device, but one focuses on processing speed and daily tasks while the other emphasizes relaxation and healthy habits.…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Could a zap to your face lift your mood? new trial explores FES for depression
Symptom relief Not yet recruitingThis study tests whether Functional Electrical Stimulation (FES) of facial muscles is a safe and effective way to reduce depression symptoms in people with major depressive disorder (MDD). About 60 adults with MDD who have not responded to up to two treatments will receive FES or…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Breathing your way to better heart health: new POTS study
Symptom relief Not yet recruitingThis study tests whether regular breathing exercises can improve symptoms of Postural Tachycardia Syndrome (POTS), a condition that causes dizziness and rapid heartbeat when standing. Twelve adults with POTS will practice breathing exercises daily for four weeks while researchers…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Can a tote bag replace pills? new study tests comfort kit for teens after scoliosis surgery
Symptom relief Not yet recruitingThis pilot study will test whether a 'Comfort Tote' filled with items like aromatherapy oils, stress balls, acupressure guides, and a journal can help teens aged 10-21 feel less pain, anxiety, and stress after scoliosis surgery. Half the participants will get a tote with therapeu…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Robot arm trainer could boost recovery for stroke and Parkinson's patients
Symptom relief Not yet recruitingThis study tests a robotic device designed to help people with stroke, Parkinson's disease, ALS, or mild cognitive impairment improve their arm and hand function. Thirty adults will receive standard rehabilitation, and half will also use the robot for up to 30 minutes per session…
Phase: NA • Sponsor: University of Pavia • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Could a common drug ease psoriasis? new study seeks answers
Symptom relief Not yet recruitingThis study tests whether adding a pill called pentoxifylline to standard skin creams can improve mild-to-moderate psoriasis. About 140 adults will take either the study drug or a placebo twice daily for 12 weeks. Researchers will measure changes in skin severity, itch, and qualit…
Phase: NA • Sponsor: Wasuchon Chaichan • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Could cooking and gardening boost brain health in Parkinson's? a new trial puts it to the test.
Symptom relief Not yet recruitingThis trial investigates whether doing enjoyable, meaningful activities—like cooking, gardening, or painting—can improve thinking skills and daily function in older adults with Parkinson's disease who have mild to moderate memory or thinking problems. Participants are randomly ass…
Phase: NA • Sponsor: University of Nevada, Las Vegas • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Laser boost for braces: new study tests faster tooth straightening
Symptom relief Not yet recruitingThis study tests whether adding low-level laser therapy to a minor bone-poking procedure (micro-osteoperforations) can speed up tooth movement in people with braces. About 33 patients aged 12-30 will have their canine teeth retracted after premolar extraction. The goal is to shor…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Could a simple amino acid ease rare brain disorders?
Symptom relief Not yet recruitingThis study tests a drug called N-acetyl-L-leucine for people aged 4 and older with CACNA1A gene disorders, which can cause coordination problems, dizziness, and migraines. About 60 participants will receive either the drug or a placebo, then switch, to see if it improves movement…
Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Bibliotherapy: could a book be the new prescription for student stress?
Symptom relief Not yet recruitingThis study tests whether reading specific self-help books can lower anxiety, depression, and rumination in university students aged 18-25. 110 students from health science programs will be randomly assigned to read one of two books or join a waiting list. Over 8 weeks, they will …
Phase: NA • Sponsor: Istanbul Nisantasi University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Can a 2-Week app ease anxiety and depression? norway launches large trial
Symptom relief Not yet recruitingThis study will test two smartphone apps, Tankevirus and Grubl, designed to help people with mild to moderate anxiety and depression. About 1000 Norwegian adults will use one of the apps or a placebo app for two weeks. Researchers will measure changes in symptoms and quality of l…
Phase: NA • Sponsor: University Hospital, Akershus • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Can a home workout boost brain and body in Parkinson's?
Symptom relief Not yet recruitingThis study tests a 16-week home-based exercise program for people with Parkinson's disease. Fifty participants will either do aerobic and resistance training or just stretching. The goal is to see if the program increases daily physical activity, improves thinking, and enhances q…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Mind over PCOS: theta healing trial targets fertility fears
Symptom relief Not yet recruitingThis study tests a 5-day online Theta Healing program—including meditation, visualization, and self-compassion exercises—in 142 women with PCOS. The goal is to see if it reduces fertility anxiety and improves body image compared to usual care alone. Results will be measured 6 wee…
Phase: NA • Sponsor: Ankara Medipol University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Simple leg exercises may tighten loose knees in Ehlers-Danlos syndrome
Symptom relief Not yet recruitingThis study tests whether a 12-week program of hamstring strengthening exercises can reduce knee looseness and pain in people with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorders (HSD). Twenty participants will attend two supervised exercise classes p…
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Weekly sound baths may soothe caregiver stress, tiny study hints
Symptom relief Not yet recruitingThis pilot study will test whether a weekly 60-minute sound bowl meditation, offered for six weeks, can lower stress and anxiety in unpaid caregivers. Forty adult caregivers who have been helping a chronically ill or disabled family member or friend for at least six months will p…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Just five minutes a day: simple breathing exercises may tame student anxiety
Symptom relief Not yet recruitingThis study tests whether doing a short 5-minute breathing or mindfulness exercise every day for a month can help Spanish-speaking university students feel less anxious and stressed. 240 participants will be split into four groups, each using a different technique like box breathi…
Phase: NA • Sponsor: Valencian International University (VIU) • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Heart procedure may offer lasting migraine relief, new study hopes to prove
Symptom relief Not yet recruitingThis study looks at people with migraines who also have a small hole in the heart (PFO). Participants first take a blood-thinning drug (prasugrel) to see if their migraines improve. Those who respond are randomly assigned to either continue the drug alone or have a procedure to c…
Phase: PHASE3 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Could a simple treadmill trick help COPD patients breathe better?
Symptom relief Not yet recruitingThis study tests whether a treadmill workout that combines walking downhill (eccentric) and uphill (concentric) is better than standard uphill walking for people with mild to moderate COPD. Forty participants will do 12 exercise sessions over 4 weeks. Researchers will measure leg…
Phase: NA • Sponsor: Universidad Europea de Madrid • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New device aims to ease leg swelling in lymphedema patients
Symptom relief Not yet recruitingThis study tests if a new dynamic compression device, used with compression stockings, works as well as current treatments for reducing leg swelling in people with lymphedema. About 98 adults with stage II or III lymphedema will use either the new device or standard wraps and pum…
Phase: NA • Sponsor: Jean-Paul Belgrado • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New study tracks pregnancy risks for elafibranor users
Knowledge-focused Not yet recruitingThis study follows people who took elafibranor shortly before or during pregnancy to see if it affects the baby or mother. Researchers will collect information from medical records and safety reports over about 10 years. No extra tests or treatments are required—only routine care…
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New HIV prevention drug faces drug interaction test
Knowledge-focused Not yet recruitingThis early-stage study looks at how a common tuberculosis drug, rifampin, affects levels of a new HIV prevention medicine called MK-8527. Fourteen adults with latent TB (no active symptoms) will take MK-8527 with and without rifampin. The goal is to see if the two drugs can be us…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Dutch hospital data reveals hidden patterns in IBD treatment
Knowledge-focused Not yet recruitingThis study looks at medical records from thousands of adults with Crohn's disease or ulcerative colitis treated in Dutch hospitals between 2018 and 2026. Researchers will analyze which treatments patients receive, how often they switch therapies, and how the disease affects other…
Sponsor: LOGEX • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists launch deep dive into IBD to uncover hidden clues
Knowledge-focused Not yet recruitingThis study will follow 100 adults with Crohn's disease, ulcerative colitis, or other IBD, plus their healthy relatives, for up to 3 years. Researchers will collect blood, stool, tissue samples, and imaging to track how immune cells and genetics change over time. The goal is to fi…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists hunt for fingerprints of a genetic form of Parkinson's
Knowledge-focused Not yet recruitingThis study aims to find unique biological and clinical markers for a specific genetic form of Parkinson's disease linked to the LRRK2 gene. Researchers will compare 10 people with LRRK2-related Parkinson's to 10 people with sporadic Parkinson's using blood tests, brain MRI scans,…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Brain scans reveal clues to ADHD and OCD in teens
Knowledge-focused Not yet recruitingThis study looks at brain activity in teenagers aged 10 to 17 with ADHD, OCD, or no diagnosis. Researchers will use EEG, MRI, and MEG to measure brain signals while participants do computer tasks. The goal is to understand how the brain controls thinking and behavior, which may h…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Weekly scans may make proton therapy safer for kids with cancer
Knowledge-focused Not yet recruitingThis study will enroll 100 children with solid tumors or Hodgkin lymphoma who are receiving proton therapy. Researchers will take weekly or bi-weekly CT or MRI scans during treatment to check if the original radiation plan is still accurate. If tumor coverage drops by 5% or radia…
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists launch Largest-Ever study to unravel Cystinosis's Long-Term effects
Knowledge-focused Not yet recruitingThis study follows 250 people with cystinosis, a rare genetic disorder that causes a buildup of the amino acid cystine, leading to damage in the kidneys, eyes, and other organs. Researchers will track how the disease progresses over time, including kidney function, eye problems, …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Breakfast showdown: High-Fat vs. High-Carb – which worsens blood fats?
Knowledge-focused Not yet recruitingThis study looks at how eating a high-fat or high-carb breakfast changes fat levels in the blood over 8 hours. Researchers will compare results among people with conditions like diabetes, fatty liver, or kidney disease, as well as healthy volunteers. Participants will have two ov…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists probe immune cell shifts in ICU patients to unlock sepsis secrets
Knowledge-focused Not yet recruitingThis study examines how a type of immune cell called gamma delta T cells adapt and function in critically ill patients, both with and without sepsis. Researchers will compare these cells in healthy people, non-septic ICU patients, and septic ICU patients. The goal is to understan…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could zapping the ear unlock Gut-Brain secrets in Parkinson's?
Knowledge-focused Not yet recruitingThis study investigates how stimulating the vagus nerve through the ear affects stomach function and brain activity in people with Parkinson's disease. Participants receive non-invasive electrical stimulation via a device placed on the ear, and researchers measure stomach respons…
Phase: NA • Sponsor: Spaulding Rehabilitation Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Acupuncture points may signal hidden disease activity
Knowledge-focused Not yet recruitingThis study investigates whether acupuncture points become tender or more sensitive in people with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. Researchers will compare skin temperature, blood flow, and pain sensitivity at specific body points b…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could pomegranate supplements help heal the gut in Alcohol-Related liver disease?
Knowledge-focused Not yet recruitingThis study investigates how pomegranate dietary supplements influence gut bacteria and inflammation in people with alcohol use disorder and alcohol-related liver disease. Researchers will measure levels of beneficial gut metabolites called urolithins and inflammatory markers in b…
Sponsor: University of Louisville • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Smart sensors could track brain disease at home
Knowledge-focused Not yet recruitingThis study will test whether wearable sensors can accurately monitor movement problems in people with progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). About 60 participants will wear small sensors on their chest, ankles, and wrists while doing simple task…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Large survey aims to uncover hidden pain in restless legs syndrome
Knowledge-focused Not yet recruitingThis study surveys 1,000 adults with Restless Legs Syndrome (RLS) to find out how often pain is part of their symptoms and how it affects their daily lives. Participants fill out an online questionnaire about their medical history, sleep, pain, and quality of life. The goal is to…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Dermatology study aims to cut unnecessary clinic visits with simple surveys
Knowledge-focused Not yet recruitingThis study tests whether letting patients report their symptoms online can help doctors schedule follow-up visits only when needed. About 250 adults with chronic skin conditions like eczema or psoriasis will either get standard fixed appointments or flexible scheduling based on m…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New program aims to smooth healthcare transition for teens with rare hormone disorder
Knowledge-focused Not yet recruitingThis study tests a structured program to help 40 adolescents and young adults with congenital adrenal hyperplasia (CAH) move from pediatric to adult healthcare. Participants will learn about their condition, emergency preparedness, and self-management. The goal is to see if the p…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Spine fracture study to reveal hidden degeneration risks
Knowledge-focused Not yet recruitingThis observational study will follow 150 people with thoracolumbar spine fractures to see how the injury and its treatment (surgery or non-surgical care) affect joint and disc degeneration over time. Researchers will compare CT scans and pain scores between treated patients and a…
Sponsor: Sklifosovsky Institute of Emergency Care • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Virtual reality fights pharmacy stigma for sickle cell patients
Knowledge-focused Not yet recruitingThis study tests whether a computer simulation can help pharmacists and pharmacy students better understand the pain struggles of sickle cell disease patients. About 200 healthcare professionals will use a point-of-view simulation and then complete surveys to see if their misconc…
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Chewing gum test reveals hidden impact of gum disease
Knowledge-focused Not yet recruitingThis study will measure how well people with gum disease can chew. One hundred adults with periodontitis will chew a special gum for 20 cycles to test their chewing performance. Researchers will also check the severity of their gum disease to see if there is a link. This is an ob…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Could a simple blood test predict lupus in children with ITP?
Knowledge-focused Not yet recruitingThis study looks at children with immune thrombocytopenic purpura (ITP) who also have certain antibodies, as they are at higher risk of developing lupus. Researchers will analyze blood samples to track immune cell changes and markers that may signal the transition to lupus. The g…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Tiny study asks: can spine specialists see the same thing on CT?
Knowledge-focused Not yet recruitingThis study checks how consistently six doctors can grade degeneration of the small joints in the spine (facet joints) using CT scans. It includes 12 patients and uses the Pathria scale. The goal is to see if the grading method is reliable, not to test a treatment.
Sponsor: Sklifosovsky Institute of Emergency Care • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Mass screening aims to catch silent killers early in pakistan
Knowledge-focused Not yet recruitingThis study screens adults aged 18 and older in suburban and peri-urban areas of Faisalabad, Pakistan, for four major noncommunicable diseases: diabetes, hypertension, obesity, and high cholesterol. Participants who are found to have these conditions are referred to doctors for st…
Sponsor: Getz Pharma • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists probe sonic hedgehog pathway for clues to brain AVM treatment
Knowledge-focused Not yet recruitingThis study investigates the role of the Sonic Hedgehog signaling pathway in brain arteriovenous malformations (AVMs), abnormal tangles of blood vessels that can cause bleeding or stroke. Researchers will analyze leftover brain tissue from 20–30 adults undergoing AVM surgery and c…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Genetic clue may unlock why lupus hits some people harder
Knowledge-focused Not yet recruitingThis study investigates whether a specific gene variation (ICOS) is linked to developing systemic lupus erythematosus (SLE) and how severe the disease becomes. Researchers will analyze blood samples from 30 people diagnosed with SLE to look for patterns in the ICOS gene. The goal…
Sponsor: South Valley University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Brain scans and Decision-Making tasks aim to uncover OCD's hidden markers
Knowledge-focused Not yet recruitingThis study looks for brain-based markers (biomarkers) of obsessive-compulsive disorder (OCD) in people with severe, hard-to-treat symptoms. Participants complete decision-making tasks and are exposed to personal OCD triggers while their brain activity is recorded with EEG and the…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Tight bands on legs may boost workout benefits for lung disease patients
Knowledge-focused Not yet recruitingThis study tests whether using a blood flow restriction (BFR) device during exercise can increase muscle fatigue in people with COPD, potentially making rehab more effective. Forty participants will do one session of resistance or cycling exercise with and without BFR. The goal i…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Could HIV treatment choice affect sleep? new study investigates
Knowledge-focused Not yet recruitingThis study looks at sleep health in people with HIV who are on different antiretroviral therapies. Some participants switch from a dolutegravir-based regimen to a doravirine-based one, while others stay on dolutegravir. Sleep is measured using questionnaires, wrist-worn activity …
Phase: PHASE4 • Sponsor: University of Witwatersrand, South Africa • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Smartwatches may spot IBD flares before symptoms start
Knowledge-focused Not yet recruitingThis study explores whether changes in heart rate, sleep, and activity measured by a person's own smartwatch can predict flare-ups in inflammatory bowel disease (IBD). Six hundred adults with Crohn's disease or ulcerative colitis who already own a compatible device will participa…
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can a blood test or eye scan predict pregnancy risks?
Knowledge-focused Not yet recruitingThis study will follow 5,500 first-time pregnant women to see if blood tests and eye scans can predict complications like preeclampsia, fetal growth restriction, and gestational diabetes. Researchers will collect samples and images at different points during pregnancy and compare…
Sponsor: Medicines360 • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Brain zap study probes inflammation link in Parkinson's
Knowledge-focused Not yet recruitingThis study investigates whether deep brain stimulation (DBS) of the subthalamic nucleus alters inflammation in people with Parkinson's disease. Researchers will measure inflammatory and neurodegenerative markers in the blood of 90 participants before and after DBS surgery, compar…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Radioactive tracer reveals how potential Crohn's drug moves through the body
Knowledge-focused Not yet recruitingThis trial in 8 healthy men aged 30–65 examines how the body absorbs, breaks down, and eliminates ontunisertib, an experimental oral drug for fibrostenotic Crohn's disease. Participants receive a single dose of the drug with a radioactive label, allowing researchers to track its …
Phase: PHASE1 • Sponsor: Agomab Spain S.L.U. • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can your balance predict motion sickness? new study investigates
Knowledge-focused Not yet recruitingThis study will measure balance, coordination, and reaction time in 41 adults aged 18-40 who experience motion sickness. Participants will complete a series of physical tests and a controlled motion sickness provocation session. The goal is to see how these sensorimotor skills re…
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Thyroid hormones may hold clues to kidney disease progression
Knowledge-focused Not yet recruitingThis observational study will measure thyroid hormone levels in stored blood and urine samples from 51 people with severe chronic kidney disease (stages 4 and 5). Researchers aim to understand how these hormones differ in patients with and without polycystic kidney disease. The s…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
800-Patient study aims to unlock secrets of autoimmune liver disease
Knowledge-focused Not yet recruitingThis French study will collect medical data and biological samples from 800 people with autoimmune liver diseases. Researchers hope to identify new markers that explain why some patients respond well to treatment while others do not. The goal is to better understand the immune me…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Can AI predict heart trouble in IBD patients?
Knowledge-focused Not yet recruitingThis study looks at people with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, to better understand their risk of serious heart problems like stroke and heart attack. Researchers will collect information on therapy, disease activity, lifestyle…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Wearable sensors could bring duchenne monitoring home
Knowledge-focused Not yet recruitingThis study tests whether a wearable sensor (Syde device) can reliably measure arm and hand function in boys with Duchenne muscular dystrophy who can no longer walk. Current tests are done in clinics and may miss small changes. The goal is to see if home-based digital monitoring i…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Study examines which IBD drugs are safer for seniors
Knowledge-focused Not yet recruitingThis study looked at nearly 24,000 older adults (65+) with ulcerative colitis or Crohn's disease to see if certain advanced treatments lead to more infections. Researchers compared patients taking ENTYVIO, TNF-alpha inhibitors, or ustekinumab using Medicare claims data from 2016 …
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Blood test clues for mental health disorders?
Knowledge-focused Not yet recruitingThis study will examine whether certain RNA molecules in the blood are different in people with psychiatric disorders like schizophrenia, depression, bipolar disorder, OCD, and panic disorder. Researchers will compare these molecules in patients who are not currently on medicatio…
Sponsor: Carmen Concerto • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Tiny preemies, big gut mystery: can bacteria predict a deadly condition?
Knowledge-focused Not yet recruitingThis study looks at how 'leaky' the gut is and what bacteria live in the intestines of 150 very low birth weight preterm babies. Researchers want to understand why some babies develop a life-threatening gut emergency called NEC. They will measure gut permeability using harmless s…
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Air pollution may worsen cystic fibrosis in kids, study hopes to find out
Knowledge-focused Not yet recruitingThis study will enroll 200 children with cystic fibrosis (100 Hispanic, 100 non-Hispanic white) to measure indoor and outdoor air pollution and see how it relates to lung function, inflammation, and airway bacteria. Researchers hope to understand why Hispanic children often have …
Sponsor: Seattle Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New online toolkit aims to boost cancer screening in lynch syndrome families
Knowledge-focused Not yet recruitingThis study tests an online tool called 'Let's Talk' designed to help people with Lynch syndrome encourage their relatives to get screened for the condition. Lynch syndrome is a genetic disorder that raises cancer risk, and only about half of close relatives currently get tested. …
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Simple CT scan could reveal hidden heart risks in HIV patients
Knowledge-focused Not yet recruitingThis study investigates whether a simple coronary CT scan can detect early signs of heart disease in people with HIV. Researchers will measure calcium buildup in the heart arteries of 384 Mexican adults with HIV who have undetectable viral loads. The goal is to better understand …
Sponsor: Instituto Mexicano del Seguro Social • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Dental scans and AI could spot rare bone diseases faster
Knowledge-focused Not yet recruitingThis study will take 3D scans of the inside of the mouth from 240 people with rare bone or cartilage diseases and from healthy volunteers. Researchers will use shape analysis and artificial intelligence to see if these scans can help tell different diseases apart. The goal is to …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could cousins be as good as siblings for stem cell donation?
Knowledge-focused Not yet recruitingThis study looks at whether using a cousin as a stem cell donor works as well as using a sibling for people with blood cancers. Researchers will compare survival, relapse, and side effects like graft-versus-host disease in patients who received a transplant from either a cousin o…
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Cutting-Edge DNA sequencing could end diagnostic nightmares for brain disorders
Knowledge-focused Not yet recruitingThis study will test two advanced DNA sequencing methods—long-read sequencing and optical genome mapping—to find hidden genetic causes of neurogenetic diseases. Researchers will analyze skin biopsy samples from 304 people aged 6 to 60 who have or may have these conditions. The go…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Brain fog after lymphoma: study probes lasting cognitive effects of chemotherapy
Knowledge-focused Not yet recruitingThis study looks at thinking skills, memory, and quality of life in people who are 3 to 5 years past successful treatment for Hodgkin lymphoma or certain types of B-cell lymphoma. Participants take a series of tests and questionnaires once during a regular follow-up visit. The go…
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study tests if videos can boost Parents' knowledge of preemie eye disease screening
Knowledge-focused Not yet recruitingThis trial aims to see if educational videos or audio messages can improve parents' knowledge and practices about retinopathy of prematurity (ROP) screening. About 99 parents of premature infants in Karachi will receive either a video, audio, or standard pamphlet. Their understan…
Phase: NA • Sponsor: Aga Khan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Unnecessary test? study questions routine throat tube before reflux surgery
Knowledge-focused Not yet recruitingThis study looks at whether people with acid reflux or a hiatal hernia can safely skip a test called esophageal manometry before their surgery. The test, which involves a thin tube through the nose to measure throat muscles, can be uncomfortable and delay surgery. Researchers wil…
Phase: NA • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists create atlas of rare lymphoma to unlock new treatment clues
Knowledge-focused Not yet recruitingThis observational study will analyze tissue samples from 400 people with MALT lymphoma, a slow-growing cancer. Researchers aim to build a comprehensive molecular and cellular map of the disease across different body sites. The goal is to identify tumor subtypes and biomarkers th…
Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Could skipping bowel prep before colon surgery be just as safe?
Knowledge-focused Not yet recruitingThis study looks at whether it's safe to skip mechanical bowel preparation (the drink that cleans out your colon) before colon surgery. Currently, the best practice combines that drink with antibiotics to prevent infections. The trial will compare two groups: one getting the drin…
Phase: NA • Sponsor: Mount Sinai Hospital, Canada • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists track hidden threat of antibiotic resistance in lung patients
Knowledge-focused Not yet recruitingThis study follows people with chronic lung diseases like bronchiectasis, cystic fibrosis, and COPD to understand how bacteria become resistant to antibiotics. Researchers will collect samples and health data over time to map resistance patterns and genetic causes. The goal is to…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Long-Term study aims to unlock mystery of joint hypermobility and chronic illness
Knowledge-focused Not yet recruitingThis study will follow 100 health science students for at least 10 years to understand why some people with very flexible joints (hypermobility) develop chronic pain, fatigue, and other health issues while others do not. Researchers will measure balance, heart rate, and quality o…
Sponsor: Clarkson University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Could low vitamin c weaken bones? new study investigates
Knowledge-focused Not yet recruitingThis observational study will check vitamin C levels in 40 people with osteoporosis, comparing those who have had a spine fracture to those who haven't. The goal is to see if lower vitamin C is more common in the fracture group. No treatment is given; the study simply measures an…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New tool helps teens choose between two lifelong dental paths
Knowledge-focused Not yet recruitingThis study aims to create a patient decision aid for young people aged 11-18 who are missing one or both upper front teeth, a condition affecting 1 in 50 people. Researchers will interview patients and their parents, and hold focus groups with clinicians, to understand what matte…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple test during pregnancy prevent premature birth?
Knowledge-focused Not yet recruitingThis study will test whether regularly checking pregnant women for hidden genital infections can reduce problems like preterm birth and low birth weight. 250 pregnant women will be split into two groups: one gets the extra screening and treatment, the other gets standard care. Th…
Phase: NA • Sponsor: Universidade Federal do Pampa • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood test could predict bleeding risk in cancer patients
Knowledge-focused Not yet recruitingThis study aims to create a score that uses a special blood test to predict bleeding risk in people with blood cancers and very low platelet counts. Researchers will take an extra blood sample from 410 participants and analyze it with viscoelastometric tests. The goal is to ident…
Sponsor: Centre Hospitalier Annecy Genevois • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could your work schedule push you to gamble?
Knowledge-focused Not yet recruitingThis study looks at whether working unusual hours or having long idle periods at work makes people more likely to develop problem gambling. Researchers will survey 1,600 employed adults in France who have gambled at least once in the past year. The goal is to understand how work …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Egyptian HAE patients to be studied for better care insights
Knowledge-focused Not yet recruitingThis study will collect information from medical records and routine clinic visits of 100 people in Egypt with hereditary angioedema (HAE) type I or II. The goal is to understand how the condition is diagnosed and managed in current medical practice. No new treatments are being t…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks Risdiplam's Real-World impact on spinal muscle atrophy
Knowledge-focused Not yet recruitingThis study will observe 30 children with type I or type II spinal muscle atrophy who are taking risdiplam. Researchers will track motor function improvements over 24 months using standard tests. The goal is to see how well the drug works in everyday medical practice.
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heart risk under the knife: new study tracks anesthesia dangers in rare cardiac condition
Knowledge-focused Not yet recruitingThis observational study will follow 200 adults with Brugada Syndrome who need anesthesia for surgery or other procedures. Researchers want to see how often dangerous heart rhythms occur during and up to 30 days after anesthesia. They will also check if certain anesthetic drugs o…
Sponsor: Hospital Clinic of Barcelona • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study to measure drug levels in breast milk of moms on TREMFYA
Knowledge-focused Not yet recruitingThis study will measure how much of the drug TREMFYA (guselkumab) passes into breast milk of 10 nursing women who are already taking it for conditions like psoriasis, psoriatic arthritis, ulcerative colitis, or Crohn's disease. Researchers will collect milk samples to estimate th…
Phase: PHASE4 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain zap study aims to decode OCD's Approach-Avoidance conflict
Knowledge-focused Not yet recruitingThis study will implant deep brain stimulation devices in 10 adults with severe, treatment-resistant OCD to record brain activity during approach and avoidance tasks. Researchers will compare clinic-based and at-home recordings to find neural markers of OCD symptoms. The goal is …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Veterans with vision loss may get new rehab tools
Knowledge-focused Not yet recruitingThis study aims to develop new methods to help veterans with vision loss caused by age-related macular degeneration. About 20 veterans aged 50 and older with reduced vision will take part. Researchers will measure how well they recognize objects and how their brains respond befor…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a sedative improve blood flow in septic shock? a pilot study investigates
Knowledge-focused Not yet recruitingThis study looks at how the sedative dexmedetomidine affects the smallest blood vessels in people with septic shock, a life-threatening condition caused by severe infection. Researchers will measure blood flow in the tongue's tiny vessels and other key blood pressure indicators b…
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks safety of eplontersen in patients with liver transplants
Knowledge-focused Not yet recruitingThis observational study monitors the long-term safety of eplontersen, a treatment for transthyretin amyloidosis, in patients who have had a liver transplant or have severe liver impairment. Researchers will track side effects, lab changes, and serious health events in about 320 …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple WhatsApp message save lives? chile tests new screening nudge
Knowledge-focused Not yet recruitingThis study will send different types of WhatsApp messages to 235,000 people in Chile who are due for cancer or chronic disease screenings. Researchers want to see if the way a message is worded (basic, risk-focused, or peace-of-mind) and whether it mentions one test or both tests…
Phase: NA • Sponsor: University of Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Patient voices take center stage in haemophilia a treatment decisions
Knowledge-focused Not yet recruitingThis study asks adults with haemophilia A in Germany to complete an online survey about their preferences for preventive treatments. Participants choose between hypothetical treatment options that vary in effectiveness, safety, and how they are given. The goal is to understand wh…
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists launch 5-year watch on rare genetic Parkinson's to unlock disease secrets
Knowledge-focused Not yet recruitingThis study follows 70 people with PRKN- or PINK1-linked Parkinson's disease, as well as those with typical Parkinson's and healthy volunteers, over 5 years. Researchers will track movement, thinking, and mood symptoms, and collect blood, urine, and optional spinal fluid or muscle…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a Plant-Derived drug improve blood flow in septic shock?
Knowledge-focused Not yet recruitingThis pilot study will test a drug called anisodamine in 20 adults with septic shock who are on a ventilator. The goal is to see if the drug can improve blood flow in small blood vessels and help with a phenomenon called 'vascular waterfall.' This is a very early study to gather i…
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a light cap boost brain power in kids with sickle cell?
Knowledge-focused Not yet recruitingThis study tests whether shining a special light on the head (transcranial photobiomodulation) can improve oxygen use and thinking skills in children with sickle cell disease. The brain needs steady oxygen, but sickle cell can reduce blood flow. Researchers will randomly assign 6…
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Which contact method best warns families of hidden cholesterol danger?
Knowledge-focused Not yet recruitingThis study compares two approaches to notify relatives of people diagnosed with familial hypercholesterolemia (FH), a genetic condition causing very high cholesterol. One method lets patients share information themselves; the other has the study team contact relatives directly. R…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Stomach cancer study may spare some patients unnecessary surgery
Knowledge-focused Not yet recruitingThis study looks at whether a tumor's DNA repair status (MMR) changes how well the presence of cancer cells in lymph vessels predicts spread to lymph nodes in stomach cancer. Researchers will review medical records of 3,000 patients who had surgery. The goal is to improve risk as…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
French biobank aims to unlock secrets of rare brain vessel diseases
Knowledge-focused Not yet recruitingThis study will collect blood samples and medical information from 600 adults with rare diseases affecting blood vessels in the brain and eye, such as CADASIL and cavernous angioma. The goal is to create a long-term biobank that researchers can use to find biomarkers and better u…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Personalized videos may make colonoscopy prep easier for IBD patients
Knowledge-focused Not yet recruitingThis study tests whether watching a short video tailored to their specific type of inflammatory bowel disease (IBD) helps patients better prepare their bowel for a colonoscopy. About 600 adults with ulcerative colitis or Crohn's disease will be randomly assigned to receive either…
Phase: NA • Sponsor: Jie Liang • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can we predict breathing problems in cleft surgery? new study aims to find out
Knowledge-focused Not yet recruitingThis study observes 150 infants and toddlers having cleft lip or palate repair to understand how often breathing complications occur and what factors increase risk. Researchers will use standard airway scoring tools to see if they can predict problems like laryngospasm or low oxy…
Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
MRI may reveal who benefits most from physical therapy for back pain
Knowledge-focused Not yet recruitingThis study reviews medical records of 120 adults with low back pain who completed 15 sessions of physical therapy. Researchers will group patients based on their MRI results (disc herniation, disc degeneration, or normal findings) to see if certain types of back pain respond bett…
Phase: NA • Sponsor: Bahçeşehir University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Infant skull study aims to unlock secrets of craniosynostosis
Knowledge-focused Not yet recruitingThis study looks at skull bone samples from 80 infants aged 3 to 12 months who have craniosynostosis, a condition where skull bones fuse too early. Researchers will measure the bone's strength, structure, and tissue makeup both near and far from the fused area. The goal is to bet…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Tiny study could unlock secrets of genetic heart failure
Knowledge-focused Not yet recruitingThis study follows 10 Chinese adults who have a specific gene mutation (BAG3) linked to dilated cardiomyopathy, a condition where the heart becomes enlarged and weak. Researchers will track changes in heart function, symptoms, and biomarkers over time to better understand how the…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Eye study aims to map corneal thickness in common vision problems
Knowledge-focused Not yet recruitingThis study will use a special imaging device (AS-OCT) to measure the thickness of the cornea's outer layer in 360 adults with nearsightedness, farsightedness, astigmatism, or normal vision. The goal is to see if different vision problems have unique thickness patterns. Participan…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heartburn's hidden toll: study links GERD to body pain and poor posture
Knowledge-focused Not yet recruitingThis study looks at how severe GERD symptoms are linked to posture problems, muscle pain, and physical activity in adults aged 18 to 65. Researchers will measure symptoms, take posture photos, and ask about pain and exercise. No treatment is given—the goal is simply to understand…
Sponsor: Karabuk University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Hidden brain disease study aims to prevent stroke and dementia
Knowledge-focused Not yet recruitingThis study looks at people aged 65 and older who have signs of brain blood vessel disease on a past scan but no history of stroke, dementia, or other major brain conditions. Researchers will collect information on daily function, thinking skills, speech, and any new vascular even…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists investigate mysterious loin pain in kidney disease
Knowledge-focused Not yet recruitingThis study looks at what changes occur in the kidneys, urine, and blood when people with IgA nephropathy (IgAN) experience loin pain. Researchers will use MRI scans and lab tests to compare findings during a pain episode and when pain-free. The goal is to better understand the ca…
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Parkinson's Patients' rhythm skills tested on and off medication
Knowledge-focused Not yet recruitingThis study looks at how dopamine levels affect the ability to keep a steady beat in people with early-stage Parkinson's disease. 34 participants will do simple tapping tasks both on their usual levodopa medication and after skipping it for 12 hours. The goal is to understand whet…
Phase: NA • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood test may reveal hidden heart damage in AFib patients
Knowledge-focused Not yet recruitingThis study looks at 150 people with persistent atrial fibrillation (a type of irregular heartbeat) who are scheduled for a heart procedure called ablation. Researchers want to see if levels of a protein called BDNF in the blood are linked to signs of heart muscle damage (atrial c…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood marker may reveal hidden inflammation in arthritis patients
Knowledge-focused Not yet recruitingThis study will measure a protein called IL-41 in the blood of 90 people with ankylosing spondylitis or psoriatic arthritis, plus healthy volunteers. Researchers want to see if higher levels of this protein are linked to more active disease. The goal is to find a simple blood tes…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Breastfeeding moms needed for drug safety study
Knowledge-focused Not yet recruitingThis study will measure how much of the drug mirikizumab passes into breast milk in 14 breastfeeding women who take it for inflammatory bowel disease. Participants will provide milk samples over several weeks. The goal is to understand potential exposure to nursing infants, helpi…
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can mindfulness ease trauma for Justice-Involved black teens?
Knowledge-focused Not yet recruitingThis study looks at whether mindfulness-based stress reduction can help Black teenage girls who have been involved with the justice system and their parents or caregivers. About 90 participants will report on stress, PTSD symptoms, and other outcomes before and after the program.…
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to track dangerous infections in kids with sickle cell disease
Knowledge-focused Not yet recruitingThis study will look at medical records of 350 children with sickle cell disease in France who had serious bacterial infections between 2020 and 2025. The goal is to find out which bacteria are causing these infections today, especially with new vaccines available. The results co…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Sniffing madeleines before a sugar drink: can a pleasant scent change your blood sugar response?
Knowledge-focused Not yet recruitingThis study will test whether smelling a pleasant food odor (madeleine scent) before drinking a sugary solution changes how the body handles blood sugar. Twenty adults, some with obesity and mild insulin resistance and some without, will each undergo two sessions: one with the sce…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
HIV study aims to uncover hidden health risks in aging patients
Knowledge-focused Not yet recruitingThis study will look at over 12,000 adults in the Basque Country to compare how common multiple health conditions, taking many medications, and getting risky prescriptions are among people with HIV versus the general population. Researchers will use electronic health records to g…
Sponsor: Biogipuzkoa Health Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
New study aims to unlock fertility secrets in PCOS
Knowledge-focused Not yet recruitingThis study will follow 473 women with polycystic ovary syndrome (PCOS) and a control group to understand what affects their ability to get pregnant. Researchers will look at medical history, hormone levels, and lifestyle factors to see which ones help or hinder natural or assiste…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New study aims to find best breathing support for COPD patients during lung surgery
Knowledge-focused Not yet recruitingThis study looks at how different ventilator pressure settings affect breathing and heart function in people with COPD undergoing lung surgery. Forty-eight patients will each try three short pressure settings in random order. The goal is to find which setting keeps the lungs open…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
HIV and fatty liver: scientists hunt for hidden clues in the blood
Knowledge-focused Not yet recruitingThis study looks at how HIV might change the way the body handles fats in the liver, leading to fatty liver disease. Researchers will collect one blood sample from 120 adults: people with HIV and fatty liver, people without HIV but with fatty liver, and healthy controls. By analy…
Sponsor: Yinzhong Shen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain implant study aims to unlock secrets of Parkinson's sleep problems
Knowledge-focused Not yet recruitingThis study looks at how a brain region called the subthalamic nucleus (STN) is involved in sleep and wakefulness in people with Parkinson's disease. Researchers will record brain activity during sleep using special electrodes already implanted for deep brain stimulation. The goal…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Parkinson's study probes hidden links between arm function and body sense
Knowledge-focused Not yet recruitingThis study looks at how Parkinson's disease affects arm and hand skills, trunk control, and body awareness. Researchers will compare 118 people with Parkinson's (ages 50-80) to healthy adults using tests like pegboard, grip strength, and reaction time. The goal is to understand t…
Sponsor: Baskent University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Skin deep: european study probes the hidden emotional toll of skin diseases
Knowledge-focused Not yet recruitingThis study looks at how people with skin conditions (like eczema, psoriasis, or skin cancer) manage stress, feel lonely, and bounce back from challenges. Researchers will compare 375 adults with and without skin disease across 15 European countries using questionnaires. The goal …
Phase: NA • Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New study aims to uncover hidden clues in rare liver disease
Knowledge-focused Not yet recruitingThis study follows 45 adults with alpha-1 antitrypsin deficiency (a genetic condition that can cause liver damage) to learn how the disease progresses. Researchers will analyze stored blood and liver tissue samples to find biomarkers and understand the molecular pathways involved…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New study to uncover how sleeve gastrectomy affects gut health
Knowledge-focused Not yet recruitingThis study follows 40 adults who recently had laparoscopic sleeve gastrectomy for obesity. Over 6 months, researchers will measure changes in blood sugar, cholesterol, gut barrier markers, and digestive symptoms. The goal is to understand how the surgery affects gut health and me…
Sponsor: Toros University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
How strong should you be? new study aims to find out
Knowledge-focused Not yet recruitingThis study will measure leg and handgrip strength in about 2,800 healthy adults and people with chronic lung diseases across Spain, Portugal, and Italy. Researchers want to create normal muscle strength values for these populations and see if the same standards can apply to peopl…
Sponsor: University of Alcala • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
3D-Printed brain models could make aneurysm repair safer
Knowledge-focused Not yet recruitingThis study looks at whether using a 3D-printed copy of a patient's brain aneurysm can help doctors plan treatment and avoid problems. About 40 adults with unruptured aneurysms will have their aneurysm printed from scans, then doctors will practice the procedure on the model befor…
Phase: NA • Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Scientists to examine liver tissue after gene therapy for hemophilia
Knowledge-focused Not yet recruitingThis observational study will take small liver samples from 8 adults with hemophilia A or B who had gene therapy at least 6 months ago. Researchers want to see how the gene therapy affected liver cells, including how many cells still carry the therapy and whether there is any liv…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Gene therapy readiness check: new study maps virus immunity in muscle disease patients
Knowledge-focused Not yet recruitingThis study will test blood samples from 450 people aged 6 to 60 with inherited neuromuscular diseases to see if they have antibodies that could block gene therapy viruses (AAVs). The goal is to understand how common these antibodies are and which patients might be good candidates…
Phase: NA • Sponsor: Genethon • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Could cutting salt soothe your skin? new study investigates
Knowledge-focused Not yet recruitingThis study looks at whether changing how much salt you eat can affect skin sodium levels and the severity of eczema or psoriasis. Fifty adults will follow a low-salt diet and take either sodium tablets or a placebo for several weeks. The goal is to see if this approach is practic…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
1,000 gene carriers tracked to unlock amyloidosis secrets
Knowledge-focused Not yet recruitingThis study is a registry that will collect health information from 1,000 people who carry the gene for hereditary amyloidosis, including those with and without symptoms. Researchers will track who develops the disease and how it progresses, including the need for heart transplant…
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Brain implant study aims to decode Parkinson's mental symptoms
Knowledge-focused Not yet recruitingThis study looks at brain activity recorded from deep brain stimulation (DBS) devices in 20 people with Parkinson's disease. Researchers want to see if certain brain signals are linked to symptoms like sudden anxiety, impulse control problems, and hallucinations. Participants wil…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Hidden struggles: Parkinson's Patients' mental health under the microscope
Knowledge-focused Not yet recruitingThis study will measure how common and severe depression, anxiety, and sleep disorders are in 100 people with idiopathic Parkinson's disease. Researchers will use standard rating scales to assess these symptoms and see how they relate to the disease. The goal is to help doctors r…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Tiny plastics in our food may fuel Crohn's inflammation, scientists investigate
Knowledge-focused Not yet recruitingThis study will look at whether tiny plastic particles found in food and water are linked to Crohn's disease. Researchers will compare 90 people—some with Crohn's and some without—to see if those with Crohn's have more plastic particles in their blood and gut, and how that affect…
Sponsor: Mak Wing Yan • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New study aims to boost cervical cancer screening for women with HIV
Knowledge-focused Not yet recruitingThis study looks at how to make cervical cancer screening easier for women with HIV, who are at higher risk for this cancer. Researchers will talk to patients and doctors to find out what gets in the way of screening and follow-up care. They will also explore using HPV self-testi…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Heart scarring in HIV: researchers probe substance use link
Knowledge-focused Not yet recruitingThis observational study will use cardiac MRI to examine how stimulant and polysubstance use affects heart scarring and inflammation in 400 people with and without HIV. Participants will have one study visit for a detailed heart scan. The goal is to better understand the combined…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Health workers without medical degrees may help detect high blood pressure in new moms
Knowledge-focused Not yet recruitingThis study looks at whether allied-health professionals (like pharmacists or nurses) can help recruit and follow women who had preeclampsia during pregnancy. Participants will check their blood pressure at home and work with a research pharmacist for 12 months. The goal is to see…
Phase: NA • Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Smart sensors and AI aim to decode your blood sugar for tailored diet advice
Knowledge-focused Not yet recruitingThis study uses a wearable glucose sensor and artificial intelligence to understand how healthy adults process sugar. Researchers will track blood sugar patterns for 14 days and link them to diet, activity, and health measures. The goal is to develop personalized nutrition tools …
Sponsor: IMDEA Food • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Can ECG algorithms pinpoint dangerous heart rhythms in tetralogy of fallot patients?
Knowledge-focused Not yet recruitingThis study checks whether three common ECG-based methods can accurately locate where abnormal heart rhythms start in adults who had Tetralogy of Fallot repair. Researchers will pace the heart from known spots during a scheduled procedure and compare the predicted location to the …
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Hemophilia a bone health under the microscope: which treatment wins?
Knowledge-focused Not yet recruitingThis study will follow 50 men with severe hemophilia A for five years to compare bone density between those taking emicizumab and those taking efanesoctocog alfa. Researchers will also measure bone remodeling markers and joint health. The goal is to see if one treatment is linked…
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Scientists hunt for autism genes in large blood study
Knowledge-focused Not yet recruitingThis study aims to collect blood samples from 450 people, including individuals with autism spectrum disorder (ASD), their relatives, and healthy controls. Researchers will isolate cells from the blood to study genetic factors and biological processes linked to autism. The goal i…
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Could cutting bladder pills boost brain health in Parkinson's?
Knowledge-focused Not yet recruitingThis study looks at whether slowly reducing or stopping a type of bladder medication (antimuscarinics) can improve thinking and quality of life in people with Parkinson's disease. Twenty participants will go through periods of taking their usual dose and periods of tapering off, …
Phase: PHASE4 • Sponsor: Corporal Michael J. Crescenz VA Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Can a special walker help babies with down syndrome take their first steps?
Knowledge-focused Not yet recruitingThis study looks at whether a suspension walker is a practical tool for pre-walking infants with Down syndrome to use at home. Twelve infants aged 10-13 months will try using the walker for 20 minutes a day, 5 days a week over three months. Researchers want to see if families can…
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC